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Abstract 
 Magnetic resonance imaging (MRI) has emerged as the imaging modality of 
choice in a wide variety experimental and clinical applications. In this dissertation, I will 
describe novel MRI techniques for the characterization of neural and pulmonary vascular 
function in preclinical models of disease.  
In the first part of this dissertation, experimental results will be presented 
comparing the identification of ischemic lesions in experimental stroke using dynamic 
susceptibility contrast (DSC) and a well validated arterial spin labeling (ASL). We show 
that DSC measurements of an index of cerebral blood flow are sensitive to ischemia, 
treatment, and stroke subregions. Further, we derived a threshold of cerebral blood flow 
for ischemia as measured by DSC. Finally, we show that ischemic lesion volumes as 
defined by DSC are comparable to those defined by ASL.  
In the second part of this dissertation, a methodology of visualizing clots in 
experimental animal models of stroke is presented. Clots were rendered visible by MRI 
through the addition of a gadolinium based contrast agent during formation. Modified 
clots were used to induce an experimental embolic middle cerebral artery occlusion. 
Clots in the cerebral vasculature were visualized in vivo using MRI. Further, the efficacy 
of recombinant tissue plasminogen activator (r-tPA) and the combination of r-tPA and 
recombinant annexin-2 (rA2) was characterized by clot visualization during lysis.  
In the third part of this dissertation, we present results of the application of 
hyperpolarized helium (HP-He) in the characterization of new model of experimental 
vii 
pulmonary ischemia. The longitudinal relaxation time of HP-He is sensitive to the 
presence of paramagnetic oxygen. During ischemia, oxygen exchange from the airspaces 
of the lungs to the capillaries is hindered resulting in increased alveolar oxygen content 
which resulted in the shortening of the HP-He longitudinal relaxation time. Results of 
measurements of the HP-He relaxation time in both normal and ischemic animals are 
presented. 
In the final part of this dissertation, I will present results of a new method to 
measure pulmonary blood volume (PBV) using proton based MRI. A T1 weighted, 
inversion recovery spin echo sequence with cardiac and respiratory gating was developed 
to measure the changes in signal intensity of lung parenchyma before and after the 
injection of a long acting intravascular contrast agent. PBV is related to the signal change 
in the lung parenchyma and blood before and after contrast agent. We validate our 
method using a model of hypoxic pulmonary vasoconstriction in rats.
viii 
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1 
 Chapter I: Introduction  
1.1 Introduction to Magnetic Resonance Imaging 
Magnetic Resonance Imaging (MRI) is a powerful tool useful in measuring the structural 
and functional properties of biological tissue. The following section will review the 
fundamentals of physics germane to MRI signal acquisition and describe the ability to 
exploit these phenomena for image acquisition and contrast generation. Several sources 
were utilized in the preparation of this section including works from Bernstein (1), 
McRobbie (2), Sotak (3), Haacke (4), and Hornak (5).  
1.1.1 Spin Physics 
 An atom consists of negatively charged electrons, positively charged protons, and 
neutrally charged neutrons. The neutrons and protons comprise the atom‘s nucleus. 
Electrons orbit around the nucleus. The nucleus (as well as electrons) contains both 
orbital and spin angular momentum. The summation of the orbital and spin angular 
momentum is termed the total nuclear angular momentum and expressed as a vector, p. A 
charged particle or nucleus which possesses a nonzero angular momentum is associated 
with a magnetic moment, and can be expressed as a vector, μ. The relationship between p 
and μ  
                                                                    [1.1] 
where γ is known as the gyromagentic ratio and is specific to the nucleus. The parameter 
γ is a function of the ratio of the charge of the nucleus to its mass.  
 The magnitude of the vector p is based on the net spin, I, of the nucleus. The net spin 
is determined by the number of unpaired protons and neutrons. If, for example, there 
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exists one unpaired neutron or proton, the net spin is equal to ½. In another configuration, 
both an unpaired proton and an unpaired neutron exist within a nucleus which results in a 
net spin equal to 1. A nucleus has no net spin when both protons and neutrons are paired. 
The relationship between |p| and I is expressed as: 
                                                                    [1.2] 
where    is Plank‘s constant (6.626068 * 10-34 m2 kg/s) divided by 2π. Equation 1.2 and 
1.1indicates that if the net spin, I, of a nucleus equals 0, the magnitude of the vector p is 0 
and the nucleus has no angular momentum and no magnetic moment. The magnitude of 
μ, can be expressed as 
                                                                     [1.3] 
The direction of p is quantized in a finite number of directions. The longitudinal 
component of p, pz, is limited to     where mI consists of –I, -I+1…,I-1, I. From this, 
the longitudinal component of the magnetic moment, uz can be expressed as 
                                                                 [1.4] 
and the angle, θ, of the vector u can be expressed as    
     
  
   
                                                           [1.5] 
Figure 1.1 graphically displays the possible orientations of the magnetic dipole moment 
of a net spin-1/2 nucleus.  
 
 
3 
1.1.2 Establishing the Boltzmann Equilibrium 
 Considering a single nucleus with magnetic dipole moment, μ, placed inside an 
external magnetic field, Bo, the energy of that nucleus is given by: 
                                                              [1.6] 
Substituting equation 1.3, 1.4, and 1.5, equation 1.6 becomes  
   
  
 
                                                         [1.7] 
for a spin-1/2 system. A spin-1/2 nucleus can have only two possible orientations of uz 
and therefore, can have two possible energy levels. In this case the lower energy state 
(spin-up) is aligned with the external magnetic field, where as the higher energy state 
(spin-down) will be aligned anti-parallel. The difference in energy states of a spin-1/2 
nucleus is  
                                                                [1.8] 
 The magnitude of the difference in energy states is proportional to the magnetic field 
strength. Further, in the condition where the bulk spins are outside of an external 
Figure 1.1 Possible orientations of the magnetic 
dipole moment of a spin-1/2 nucleus. 
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magnetic field, equation 1.8 indicates that the difference in energy levels in 0. Outside of 
an external magnetic field, the spins have no favored orientation. When considering bulk 
nuclei, the Nuclear Magnetic Resonance (NMR) signal results from a small population 
difference of nuclei between the two energy states. This will be discussed below. An 
energy level diagram is displayed in Figure 1.2.  
1.1.3 Energy Level Transitions 
 In order to transition from spin-up to spin-down, electromagnetic (EM) radiation in 
the radio frequency (RF) wavelength must be absorbed by the spin. Conversely, a 
transition from the spin-down state to spin-up requires a release of EM radiation in the 
RF wavelength. The energy of the EM radiation required to transition from spin-up to 
spin-down is equal to the difference between the two energy states as 
                                                               [1.9] 
where ν is the frequency of the EM radiation and h is Plank‘s constant. By conservation 
of energy, equations 1.8 and 1.9 can be equated. After rearranging terms, ν is defined by 
Figure 1.2 Energy Level Diagram of spin-1/2 nuclei inside and outside the main magnet 
field, B0.  Each arrow represents individual nuclei. 
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                                                          [1.10] 
The frequency ν is the frequency of the EM radiation required to transition a spin system 
with a specified γ and Bo. The NMR signal is derived by the energy released from a spin 
as it relaxes from the spin-down state to the spin-up state. 
1.1.4 Boltzmann Equilibrium 
The distribution of the spins at each energy level is dependent on the Boltzmann 
Equilibrium expressed (for net spin-1/2 nuclei) as 
 
  
  
  
  
                                                          [1.11] 
where N± is the population of nuclei in each spin configuration state, k is the Boltzmann 
constant (1.38x10-23 Joules/°Kelvin) and T is the temperature in Kelvin. The difference in 
spin populations (  ) is expressed by 
   
   
   
                                                        [1.12] 
where N is the total number of nuclei. The population difference is therefore dependent 
on the temperature, the energy differences (which is dependent on the main magnet 
field), and the total number of nuclei.  
 The total magnetization, Mo, can be considered the sum total of the magnetic 
moments expressed as 
         
 
                                                           [1.13] 
where Nm is the number of spins and μz,m is the z component of the vector μ in the spin-I 
configuration. For the common spin-1/2 case, the magnetization is related directly to the 
population difference as 
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                                                        [1.14] 
In the spin-1/2 system, Mo will face parallel to the magnetic field, Bo at thermal 
equilibrium. The NMR signal is proportional to Mo and therefore is dependent on the 
magnetic field strength, B0 and the gyromagnetic ratio, γ.  
1.1.5 Classical Description of NMR 
 It is instructive to explore the interaction of a single spin with a magnetic moment μ 
with the main magnetic field, B0. The magnetic moment will experience a torque induced 
by B0 expressed as: 
  
  
  
                                                           [1.15] 
Thus, the torque of the system is equal to the change of angular momentum as a function 
of time. Considering the magnetic moment is equal to the angular momentum times the γ, 
equation 1.15 can be expressed as  
  
  
  
  
  
                                                            [1.16] 
This equation indicates that the magnetic moment, μ will precessing around B0. In the 
absence of any externally applied RF energy, the processional frequency of the μ can be 
described by the Larmor equation 
                                                             [1.17] 
It is further useful to describe equation 1.16 in terms of the net magnetization, M. This 
vector represents the sum of all magnetization vectors. Equation 1.16 can be rewritten as 
  
  
                                                            [1.18] 
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indicating that the net magnetization vector is precessing around B0. Figure 1.3 is a 
representation of the formation of the net magnetization M. The magnetic dipole moment 
vector, μ, of each nuclei is precessing around B0 with a distribution in each configuration 
according to the Boltzmann equilibrium which is represented on the left of Figure 1.3. 
There is a net number of spins precessing in the spin-up orientation. Combining the spins, 
a net magnetization vector, M is also precessing with a spin-up orientation. 
 
Figure 1.3 Left: Nuclei precess around B0 with a slight bias for the spin-up configuration. Right: The net 
magnetization vector precesses in a spin-up configuration around B0 
 
1.1.6 The Bloch Equations 
 As seen in previous sections, the net magnetization is influenced by the strength of 
the main magnetic field, Bo. It can also be influenced by the application of RF radiation, 
as previously described. The presence of RF energy creates an applied magnetic field, B1. 
The response of the net magnetization to both B0 and B1  has been described by Bloch 
(6). The equations describe dynamically changing motion of the net magnetization 
vector, M, in each of the three axes as: 
     
   
  
                    
  
  
                                  [1.19] 
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                             [ 1.20] 
     
   
  
                         
     
  
                         [1.21] 
These equations assume that B1 is oscillating and applied in the transverse (xy) plane and 
rotating with frequency ω and Bo is parallel with the z axis. When describing the Bloch 
equations, it is customary to describe the x-y plane as rotating at the Larmor frequency. 
In this treatment, the B0 components of equation 1.19 and 1.20 can be set to 0. The terms 
T2 and T1 are relaxation terms that describe the time constant of the return of the system 
to thermal equilibrium. More specifically, T2 describes the dephasing of magnetization in 
the x-y plane and T1 describe the return of the magnetization to the Boltzmann 
equilibrium. Following the application of an applied RF field (B1=0) and assuming the 
reference frame rotating at ω, the Bloch equations reduce to  
     
    
  
  
   
  
                                                         [ 1.22] 
     
   
  
  
     
  
                                                       [1.23] 
Solving for the differential equations, the time course of the transverse and longitudinal 
magnetization following the application of B1 can be described as: 
              
  
                                                           [1.24] 
              
  
                                                          [1.25] 
where α is either 1 or 2 depending if the magnetization was tipped into the transverse 
plane or inverted, respectively. The physical meaning of the time constants, T1 and T2 
will be described below. 
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1.1.7 Free Induction Decay 
 In order to understand the mechanism of NMR signal generation and contrast 
weighting, it is necessary to understand the reaction of the net magnetization vector, M to 
the application of an RF pulse in the transverse plane. In MRI and NMR experiments, the 
RF pulse flip angle is defined by the amount of rotation into the transverse plane that it 
induces on the net magnetization. The amount of rotation, or flip angle, is defined by 
                                                                [1.26] 
where η is the pulse length in seconds.  This process is depicted in Figure 1.4.  
 
Figure 1.4 Depiction of the net magnetization vector responding to an applied RF field. The longitudinal 
component of M is reduced whiled the transverse component is increased. 
The RF pulse is produced by a sinusoidal varying electrical current through a RF coil. 
The electrical current generates a magnetic field, B1, perpendicular to B0. The detection 
of the NMR signal occurs in the transverse plane to avoid the influence of the main 
magnetic field.  
 The instant that the RF pulse is disengaged, the net magnetization begins to lose its 
phase coherence through T2
* mechanisms (described below). Taken together with the 
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torque produced by the main magnetic field, the net magnetization produces a decaying, 
sinusoidal magnetic field, inducing a corresponding sinusoidal decaying electrical voltage 
in the RF coil. This is known as the free induction decay (FID). An example FID is 
depicted in Figure 1.5 
 
Figure 1.5 The time course of the transverse magnetization following an RF pulse 
The time varying magnetic field produced an electric current in the RF coil.  The 
electrical current is recorded and a Fourier transform is applied to obtain the frequency 
and amplitude of the original NRM signal.    
1.1.8 NMR Relaxation Mechanisms 
Much of the contrast produced in NMR and MRI can be obtained by exploiting 
the relaxation mechanism, T1 and T2. The relaxation times are characteristic of the tissue 
under investigation and can provide valuable information about the tissue physiology and 
the effects of disease processes. The section below will describe the origins of these 
relaxation mechanisms and techniques used to measure them.  
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1.1.8.1 T1 – Longitudinal Relaxation 
Following excitation with an applied RF pulse, the longitudinal magnetization 
recovers to Boltzmann equilibrium with the time constant, T1. This time constant is 
dependent on the efficiency in which a spin gives up energy to the surrounding lattice, or 
surrounding environment. Protons in water lose energy to the lattice very efficiently if the 
water molecule is bound to other biomolecules. Thus, bound water has a faster T1 as 
compared to free water. The effect of binding can be quantified as the molecules 
rotational rate (also known as the rotational correlation time). Rotational rates faster than 
the Larmor frequency lose energy to the lattice less efficiently. T1 contrast agents work 
by binding water and increasing the bound water molecules overall correlation time. 
Therefore, presence of a contrast agent serves to shorten the T1 of the water molecules.  
The most common methodology for measuring the longitudinal relaxation time is 
through the use of inversion recovery. The net magnetization vector is inverted to the –z 
axis through the application of a 180° RF pulse. The net magnetization will begin to 
recover to its thermal equilibrium. At varying times following the 180° inversion pulse, 
the magnetization is sampled in the transverse plane through the application of a second 
RF pulse. The longitudinal magnetization can be sampled at varying times following the 
inversion pulse. This delay between the inversion pulse and the sampling pulse is known 
as the inversion time. By fitting the sampled magnetization to equation 1.25, the 
longitudinal relaxation time can be determined. The time course of the longitudinal 
magnetization followed by an inversion depicted in Figure 1.6. 
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Figure 1.6 The time course of the longitudinal magnetization following an inversion of the magnetization.  
 
1.1.8.2 T2 – Transverse Relaxation 
Following the application of a RF pulse, magnetization is tipped onto the 
transverse plane. At the instant the RF pulse is disabled, the net magnetization is 
precessing coherently. That is, the individual spins are precessing with the same phase. 
The transverse relaxation is the process by which this phase coherence is lost. Phase 
coherence is lost due to the interaction of spins with each other. This process is known as 
spin-spin relaxation. When interacting, spins will either precess slightly faster or slower 
than their Larmor frequency. Once isolated from each other, they return to precessing at 
their Larmor frequency with different phases. Eventually all spins in the transverse plane 
will be precessing with random phases and the net magnetization in the transverse plane 
will dissipate. The exponential time constant of this process is the T2.  
Other factors contribute to the loss of phase coherence of the system including 
inhomogeneities of the main magnetic field, magnetic susceptibilities (i.e. an induced 
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magnetism in a material due to an external magnetic field), and molecular diffusion. The 
time constant of loss of magnetic coherence due to the above factors is termed T2
*. T2
* 
can be quantified as: 
 
 
  
 =
 
  
 
 
  
   
 
  
   
 
  
                                                  [1.27] 
where T2
IH, T2
MS, and T2
MD are the T2 contributions due to main magnetic field 
inhomogeneities, magnetic susceptibility, and molecular diffusion.  
To measure the T2 directly, a technique known as Hahn Spin Echo can be used 
which is depicted in Figure 1.7. A spin echo can be used to isolate the decay due only to 
the T2 and not due to inhomogeneities, magnetic susceptibility, and molecular diffusion. 
Following a 90° pulse which tips the net magnetization into the transverse plane a loss of 
phase coherence begins. After some time, TE/2, where TE is known as the echo time, a 
180° pulse is applied and the phase of spins in the transverse plane are reversed. At time 
TE, the phase of the signal is aligned and a spin-echo is produced. Although the phase 
coherence loss due to T2 spin-spin relaxation is non-recoverable, phase coherence loss 
due to magnetic field inhomogeneities, magnetic susceptibility and molecular diffusion 
Figure 1.7 Diagram of the production of a Hahn Spin Echo 
RF
90° 180°
Mxy
TE/2 TE/2
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can be reversed due to their non-random nature. This measurement can be repeated for 
different values of TE allowing for the T2 to be determined. 
1.1.9 Image Formation 
Image formation in MRI is accomplished by changing the Larmor frequency of 
spins as a function of position through the use of spatially changing magnetic fields. This 
is performed through the application of linear magnetic field gradients. The following 
section will describe how these gradients are used in order to perform slice selection and 
in-plane magnetization localization.  
1.1.9.1   Linear Magnetic Field Gradients 
Linear magnetic field gradients (LMFG) produce a change in the static magnetic 
field as a function of position. Suppose a LMFG is applied along the z-axis. The effective 
precession frequency, ωeff,  would be dependent on its position on the z axis as: 
                                                                     [1.28] 
where G is the gradient strength in units Gauss/cm, z is the distance from the isocenter of 
the magnet. Spins located at the isocenter of the magnet will experience no change in its 
Larmor frequency while spins away from the isocenter will experience a linear change in 
the Larmor frequency depending on that distance from the isocenter. 
 
1.1.9.2 Slice Selection 
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 In typical NMR spectroscopy, an RF pulse is applied and the entire sample 
within the RF coil is affected. With the addition of LMFG, spins from a finite slice can be 
selected. A gradient applied along the axis of slice selection will cause the spins to 
precess at a frequency dependent on how far it is from the isocenter of the magnet. If an 
RF pulse is applied with a frequency bandwidth, BWRF, only spins with precession 
frequencies within that bandwidth will be tipped into the transverse plane. If the center 
frequency of the RF pulse is set to the Larmor frequency, spins with precession 
frequencies of from ω–BWRF/2 to ω+BWRF/2 will be tipped into the transverse plane. 
The slice thickness, Δz, in cm, can be calculated by: 
   
    
  
                                                        [1.29] 
Figure 1.8 Graphical depiction of slice 
selection.  The slice width, Δz, is 
dependent on the gradient strength, G, 
and the RF pulse Bandwidth 
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Figure 1.8 graphically displays slice selection. Slice offset from the isocenter can be 
achieved by changing the carrier frequency of the RF pulse to values higher or lower than 
the Larmor Frequency thus exciting a different set of frequencies. The addition of slice 
selection to a standard NMR Hahn spin echo experiment is shown if Figure 1.9.  
1.1.9.3 Frequency Encoding  
 Following tipping the desired spins into the transverse plane, in plane encoding 
must be accomplished. One dimension of the in-plane encoding can be obtained using 
frequency encoding. During signal acquisition, a LMFG is applied along the axis in 
which spatial encoding is desired. The precessional frequency of the FID (or spin echo) 
of the slice selected spins is determined by their position away from the isocenter of the 
magnet in desired axis of spatial encoding. Therefore, during acquisition with frequency 
encoding, the signal will be comprised of a wide range of frequencies. 
 The field of view (FOV) in the axis of frequency encoding can be described in 
terms of the receiver bandwidth (BWreceiver) by:  
    
          
      
                                                        [1.30] 
Figure 1.9 Modification of the Hahn spin echo with slice encoding gradients. 
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where the BWreceiver is equal to the ratio of the data  points used to sample the signal and 
the acquisition time and GFreq is the gradient strength in the frequency direction. Figure 
1.10 shows a modified Hahn spin echo pulse sequence with both frequency and slice 
selection. 
 
1.1.9.4 Phase Encoding 
 Encoding in the second direction can be accomplished via modifying the phase 
of the spins. Following tipping the desired spins into the transverse plane, a gradient is 
applied in the desired axis of encoding prior to signal acquisition. The gradient 
temporarily changes the precessional frequency of the spins as a function of the spin‘s 
distance from the isocenter of the magnet. The gradient is then disabled and the 
precessional frequency returns to the Larmor frequency. Because of the temporary 
change in frequency, the spins are precessing with a different phases as a function of the 
Figure 1.10 Hahn spin echo sequence with the addition of slice and frequency encoding 
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spin‘s distance from the isocenter in the desired encoding axis. The amount of phase 
acquired by a spin at a distance d from the iosocenter in the desired encoding axis is:    
                                                                   [1.31] 
where Gphase is the gradient strength in the phase encoding direction and t is the time of 
the gradient. This equation holds true only for square shaped gradient waveforms. The 
strength of Gphase can be incrementally increased to produce a full range of phase offset 
from -180° to +180°. The minimal amount Gphase can be incrementally increased, Gp(min), 
is a function of the FOV in the phase direction, FOVp, and the gradient duration, t, can be 
calculated by: 
        
 
      
                                                        [1.32] 
Taken together with frequency encoding, incrementally increasing the phase encoding 
gradient will allow for complete mapping of the image space. The Hahn spin echo pulse 
Figure 1.11 Hahn spin echo with the addition of slice, frequency, and phase encoding. 
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sequence is shown is Figure 1.11 with the addition of phase encoding gradients. The 
gradient depicted on the phase encoding axis indicating the ability of the gradient to take 
on a number of different values. 
 Each increment of the phase encoding gradient is delayed by a recovery time, 
TR. The total acquisition time of a sequence is equal to the total number of phase 
encoding gradient increments multiplied by the TR. 
1.1.9.5 Rephasing Gradients 
 Both the slice selection gradient and the frequency encoding gradient cause the 
unwanted side of effect of dephasing the transverse relaxation. This can be remedied by 
the addition of a rephasing gradient. In the case of the slice selection, the rephasing 
Figure 1.12 A complete Hahn spin echo sequence 
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gradient serves to rephase the spins following the application of the slice selection 
gradient. In the case of the frequency encoding, a gradient is placed prior to the frequency 
encoding gradient. This gradient serves to diphase the signal such that during the 
application of the frequency encoding gradient, the spins are brought into phase 
coherence. The complete pulse sequence is given in Figure 1.12 
1.1.9.6 Gradient Echo Imaging 
 Thus far, pulse sequences have been described using Hahn spin echo signal 
excitation. Excitation can also be accomplished with a single RF pulse with a flip angle 
<= 90°. Following the RF pulse, the longitudinal magnetization is tipped into the 
transverse plane. The amount of magnetization in the transverse plane by an RF flip angle 
is given by 
                                                                      [1.33] 
Once tipped into the transverse plane, the magnetization begins to lose phase coherence 
due to the T2* relaxation mechanism described earlier. The time between the excitation 
and the signal acquisition (TE) determines the magnitude of decay due to the T2*. Similar 
to the Hahn spin echo pulse sequence, the slice selection, phase encoding, and frequency 
encoding gradients are present.  
1.1.9.7 Mapping k-space 
 For each increment of the phase-encoding gradient and an applied frequency-
encoding gradient during signal acquisition, a separate time domain signal is acquired 
consisting of signals with varied frequencies and phases. Each increment of the phase 
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encoding gradient from ±Gp can be placed in a line of a matrix. This matrix is known as 
k-space. By performing a two dimensional Fourier Transform (2DFT), the time domain 
signal can be transformed to the frequency domain which will result in a 2D MR image.  
 K-space can be mapped in a number of ways. In one method, each spin 
excitation can be used to fill one line of k-space. As mentioned above, the acquisition 
would be repeated identically except that the phase encoding gradient would be 
incrementally increased from –Gp to + Gp. Another method consists of filling multiple 
lines of k-space after a single acquisition. Applications of this methodology are described 
below. 
1.1.9.7.1 Echo Planar Imaging 
 Echo planar imaging (EPI) describes a methodology in which a multiple number 
of lines of k-space can be acquired following a single RF pulse. This method is 
Figure 1.13 An Echo Planar Imaging Sequence using the blip technique 
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advantageous due to the speed in which image acquisition can be performed. A variant of 
EPI is described in Figure 1.13. Following RF excitation an initial prephasing gradient is 
applied which sets the phase of the spins to –Gp. Next, an oscillating frequency encoding 
is applied. Prior to each oscillation of the frequency-encoding gradient, a small phase 
encoding gradient, or blip, is applied to increment the phase of the spins. K-space is 
acquired in a rectilinear fashion. While providing rapid acquisition of imaging 
information, EPI based acquisitions typically require longer echo times. In EPI 
acquisition, the echo time is defined as the time between the initial excitation and the 
acquisition of the data from the center of k-space. The longer echo times may result in 
higher sensitivity to T2
*. 
1.1.9.7.2 Turbo Spin Echo 
 In this method of rapidly traversing k-space, a modified Hahn spin-echo 
sequence is used known as the Carr-Purcell-Meiboom-Gill sequence. In this sequence, a 
90° pulse is applied followed by multiple 180° RF pulses which constantly rephrase the 
magnetization resulting in numerous spin echoes each attenuated by the T2 relaxation 
time. Between each 180° RF pulse, an incremented phase encoding gradient is applied 
followed by a phase encoding gradient during signal acquisition. In this scheme, each 
subsequent spin echo encodes a line of k-space. This process is described in Figure 1.14. 
The number of lines of k-space acquired with each 90° RF pulse defines the amount in 
which image acquisition is accelerated. Although images can be obtained rapidly, the 
signal encoded in each line of k-space will have been attenuated by a different amount 
due to T2 decay which may affect uniform sampling of k-space and cause image artifacts. 
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1.1.10 Image Weighting  
 Depending on the parameters of the pulse sequence, different image weightings 
can be achieved. The following section will describe various weightings that were 
utilized in subsequent chapters of this dissertation.  
1.1.10.1 T2,  T2*, and T1 Weighted Images 
 In order to achieve contrast in MRI, the duration of the echo time (TE) and 
recovery time (TR) can be varied. To achieve a weighting based on a tissues T1 value, 
both the recovery time and the echo time are shortened. A short TE minimizes the effect 
of T2 and T2* decay while a short TR allows for greater signal enhancement in tissue 
which has a faster T1 recovery time. To achieve T2 or T2* weighting with a spin echo or 
gradient echo sequence, respectively, a long TR and TE time should be utilized. The long 
Figure 1.14 Turbo Spin Echo Sequence.  The phase encoding gradient strength increases 
after each refocusing pulse to fill k-space.  Adapted from Hornak with permission (5). 
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TE time allows for tissue with longer transverse relaxation times to have higher signal 
intensity while the long TR reduces the influence of the longitudinal relaxation time. 
1.1.10.2 Diffusion Weighted Imaging 
 Diffusion Weighted Imaging (DWI) has emerged as a valuable tool for 
characterizing and diagnosing a number of disease states including cancer and stroke 
(7,8). Diffusion weighting is sensitive to the random Brownian motion of water. A clear 
picture of molecular motion is impossible due to a number of factors including pressure 
gradients, thermal gradients, and interaction with ionic components (9). A measurement 
of the combined effects of many processes on the molecular motion of water molecules is 
quantified as the apparent diffusion coefficient (ADC). 
 Water diffusion can be either isotropic or anisotropic. In the case of isotropic 
diffusion, water is free to move in any arbitrary axis. In anisotropic diffusion, water may 
be restricted in one or more of any arbitrary axis. In this case, the ADC can be defined as 
a tensor,          , as 
           
               
               
               
                                                         [1.34] 
The elements on the diagonal represent diffusion in each of the three orthogonal axes, 
while the off diagonal terms represent the degree of random motion between two 
orthogonal axes (1). In the case of isotropic diffusion the diffusion coefficient,          , is 
equal to the ADC in any direction. To quantify anisotropic diffusion, the average ADC 
can be calculated as: 
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                                           [1.35] 
The measurement of diffusion can be accomplished using a Hahn spin echo, echo-planar 
imaging with a pair of bipolar gradients that straddle the 180° pulse in the axis of 
diffusion encoding. Figure 1.15 displays a sample pulse sequence for diffusion imaging. 
The first of the bipolar gradient on the phase encoding axis imposes a phase shift on the 
spins, similar to the effect of the phase-encoding gradient. The second bipolar gradient 
imposes a further phase, however, because of the rephasing of the 180° RF pulse, the 
phase is reversed. The imparted phase is determined by the position of the water 
molecule from the isocenter. Therefore, a spin that is stationary will experience no phase 
change following the bipolar gradient. Spins the move from position r1 to position r2 will 
experience a phase change,   , is calculated as: 
                                                            [1.36] 
Figure 1.15 A pulse sequence for diffusion weighting on the phase encoding axis.  Reproduced 
from Bernstein with permission (1) 
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where G is the gradient strength and δ is the gradient duration. The signal intensity from 
the above sequence is given by: 
     
         
                                                   [1.37] 
where b is dependent on γ, G, δ, and the time difference between the applications of the 
gradients, tdiff. By changing the value of b over a number of repetitions of the sequence, 
the value for D can be determined for each axis of interest. 
1.1.10.3 Continuous Arterial Spin Labeling 
 Blood flow to an organ can be measured by magnetically labeling the spins of 
the inflowing blood. Generally, this technique has been referred to as arterial spin 
labeling. Many variations of the arterial spin labeling technique have been proposed. The 
experiments in this dissertation utilize the continuous arterial spin labeling (CASL) 
technique. In this technique, two coils are utilized. The first coil is used for imaging the 
organ of interest while the second is used to invert inflowing blood. In perfused tissue, 
the inverted blood causes a decrease in the voxel intensity. A subtraction of an image 
with inversion and one without (control) is related to the blood flow. Assuming a rapid 
transit time from the tagging plane to the imaging plane, the blood flow can be calculated 
as 
   
  
 
    
 
   
                                                        [1.38] 
where ρ is the density of the tissue, α is the inversion efficiency, Mo is the initial 
magnetization, ΔM is the change in signal between the inverted image and the control 
image, and   
  is the measured longitudinal relaxation time (1).  
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 Blood is inverted through Flow-Induced Adiabatic Inversion. This technique 
utilizes an RF pulse and a gradient. The gradient induces a frequency offset as a function 
of time, Δw(t), of the incoming spins from the carrier frequency as a function of position, 
r(t), as a function of time. The relationship between Δw(t) and r(t) is given by 
                                                                         [1.39] 
where ro is the tagging plane. Assuming application of the RF field on the x axis, the 
effective magnetic field,      , seen by the spins as a function of time is given by: 
      
      
 
                                                           [1.40] 
where A is the amplitude of the RF pulse. When the spins are in the same plane as the 
tagging pulse, the   axis term dominates and the spins are tipped to the transverse plane. 
As the spin moves further from the RF pulse, the   axis term dominates and the spins are 
inverted.  
 CASL has the advantage of being completely non-invasive and does not require 
the injection of a paramagnetic contrast agent. Further, given information on the 
inversion efficiency and blood and tissue magnetization, the method can give quantitative 
results of blood flow. The implementation of CASL, however, has many challenges. Due 
to the requirement of two separate RF coils for imaging and labeling, two RF 
transmission channels are necessary. Further, transit delay times in disease (i.e. stroke) 
cause magnetization decay of the labeled blood, producing an artificially lower blood 
flow measurement.  Finally, the contrast between the labeled and unlabeled images may 
be small and can result in a low contrast to noise ratio of the blood flow map.  
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1.2 Hyperpolarized Gas Physics 
The following section will discuss hyperpolarized (HP) gas physics and imaging. 
This section will serve as background for chapter 5 of this dissertation. As mentioned in 
section 1.1.2, the MRI signal is dependent on the number of nuclei imaged within the 
sample and the main magnetic field. Standard proton imaging of the lungs has proven to 
be challenging due to the low concentration of intrinsic water. To ameliorate this issue, 
MRI has been proposed using either exogenous 129Xe or 3He gas. These nuclei are both 
spin-1/2 allowing for MR-detectabiliy. At standard temperature and pressure (STP), 
however, the number of nuclei present in exogenously delivered gas is not high enough to 
produce a meaningful MR signal at Boltzmann equilibrium(10). The following section 
will discuss technology that allows for increasing the signal from 129Xe or 3He gas nuclei 
above the Boltzmann equilibrium by hyperpolarization and the different imaging 
considerations inherent in gas imaging. 
1.2.1 Polarization 
The MRI signal is ultimately determined by the difference between the numbers 
of nuclei in one energy level versus the other. To quantify this, we introduce a term, 
polarization (P), expressed by  
             
  
 
                                                       [1.41] 
At the Boltzmann equilibrium, the value of P can be readily calculated for any spin-1/2 
nuclei. By substituting Equation 1.8 and 1.12 into equation 1.41, the Boltzmann (or 
thermal) equilibrium can be expressed as  
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                                                [1.42] 
Considering the 3He nuclei (γ = 32MHZ/T) at 3.0T main magnetic field strength, the 
thermal equilibrium polarization is equal to 1.22*10-6.  
1.2.2 The Process of Hyperpolarization 
Hyperpolarization allows for the enhancement of Pthermal by inducing a 
polarization outside of the main magnetic field. Two methods of performing 
hyperpolarization of gas nuclei have been purposed. The first such method is known as 
the ‗Brute Force‘ technique which describes the method of increasing polarization 
through the use of strong magnetic fields and low temperatures. Equation 1.42 shows that 
given these conditions, a large P can be achieved. Following polarization of this type, the 
nuclei are rapidly warmed. Effective polarization for imaging and spectroscopy 
experiments can be maintained if the warming period and use is more rapid then the T1 
decay back to thermal equilibrium(11).  
The second and more popular method for in vivo applications of HP MRI is 
known as Optical Pumping (OP). Optical pumping is currently performed in two ways: 
metastable and spin exchange. The method our laboratory utilizes is the spin exchange 
method which will be described in detail in the next section. 
1.2.2.1  Spin Exchange Optical Pumping  
Spin exchange optical pumping (SEOP) has been widely used by the MRI 
community for hyperpolarization of 3He and 129Xe. The first biological application of gas 
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polarized using this method was performed by Albert et al. who imaged the excised lungs 
of mice (12). The following section will detail the physics of the SEOP process. 
 Helium gas is pressurized in a glass cell with alkali-metal atoms which is 
contained within a static magnetic field. The cell is heated to vaporize the alkali-metal. A 
circularly polarized laser is incident on the cell which causes a transition of the valance 
electrons of the alkali-metal from the 5S1/2  m=-1/2 5S1/2 orbital to the 5P1/2 m=+1/2 
orbital. In many SEOP experiments, rubidium (Rb) is typically used due to advantageous 
properties such as high vapor pressure allowing lower temperature use for vaporization 
and excitation wavelength requirement of ~795 nm which is an available laser 
wavelength from commercial vendors (13). The valance electron have an equal chance to 
decay to either 5S1/2 m=-1/2 or collide with a noble gas or nitrogen gas and switch to the 
P1/2 m=1/2 state which decays to the 5S1/2 m=+1/2 state. Electrons that have decayed to 
the 5S1/2 m=-1/2 state are immediately transitioned to the 5P1/2 m=+1/2 state by the laser 
over time causing ~100% of the Rb valance electrons into the 5S1/2 m=+1/2 state (13). 
Figure 1.16 Left: The process of optical pumping.  Rb 5S1/2 m1/2 valance electrons are excited to the 
5P1/2 m=+1/2 state.  The electron can then decay to either the 5S1/2 m=-1/2 or to the 5S1/2 m=1/2 state.  
Right: The process of spin exchange.  The m=1/2 electron interacts with the m=-1/2 3He nucleus. The 
spin state of the Rb electron and 3He nucleus is exchanged.   
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This process, depicted on the left of Figure 1.16, is known as depopulation optical 
pumping graphically describes this process. Upon collision between the polarized valance 
electrons of Rb and the unpolarized 3He nucleus the electron spin polarization of Rb is 
transferred to the 3He nucleus. As shown on the right side of Figure 1.16, the Rb valance 
electron returns to the m=-1/2 ground state at which point it is available for re-
transitioning to the m=+1/2 excited state. After a time ranging from 12-24 hours for 
polarization of 1 liter of helium gas, the temperature of the cell is reduced, the alkali 
metal returns to the solid state and the polarized helium gas is extracted from the cell 
(13).  
1.2.3 Hyperpolarized Gas Magnetic Resonance Imaging Considerations  
The MRI considerations for imaging hyperpolarized Helium (HP-He) and other HP 
nuclei are different than thermally polarized MRI in a number of ways. Of these 
considerations, the non-renewable nature of the polarization greatly affects image 
acquisition parameters. Following removal from the glass polarization cell, the gas begins 
to immediately decay from the HP state to the thermally polarized state. In the absence of 
impurities, the relaxation rate from the HP to the thermally polarized state is long (on the 
order of 40 minutes) (14). In the presence of oxygen, however, this rate is greatly 
increased (15). It is critical, therefore, that oxygen contamination is limited during the 
transfer process from the polarization cell to the patient and that the transfer happens in 
short order. The oxygen effect on this relaxation, however, can be exploited for imaging 
lung physiology, which is the basis for the experiments in chapter 5 (15-17).  
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Further, RF pulses used for MRI destroy the longitudinal magnetization. For each 
pulse, the HP longitudinal magnetization is reduced to a level equal to the cosine of the 
excitation angle. A 90° pulse, for example completely destroys the HP longitudinal 
magnetization, whereas a 5° flip angle maintains 99.6% of the HP longitudinal 
magnetization. The RF destruction of the HP longitudinal magnetization has necessitated 
the need for imaging with very low flip angles (18). Several methods have been proposed 
to ameliorate this effect on the image SNR and uniformity of k-space sampling. For 
example, images can be acquired using a centric-reordered k-space sampling scheme to 
ensure high SNR (18). Further, variable flip angle methods have been developed to more 
uniformly sample k-space (14,19). 
Because of the externally imparted polarization, the signal-to-noise ratio of HP nuclei 
imaging is almost completely independent of the strength of the main magnetic field. 
This has opened up possibilities for low magnetic field imaging which may be less costly 
and more accessible (20,21). Finally, it should be noted that most clinical MRI systems 
are primarily designed to image only protons. Hardware optimized for non-proton 
imaging will have to be more readily available for this technology to enjoy widespread 
use in the clinic.  
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1.3 MRI Characterization of Experimental Cerebral Ischemia 
The following section of this chapter will serve as a background for chapters 3 and 4 
of the dissertation. Cerebral ischemia will be discussed including it pathophysiology and 
treatment regimen. Next, aspects of MRI as they relate to cerebral ischemia will be 
discussed including diffusion, perfusion, and angiographic imaging. 
1.3.1 Pathophyisiology of Cerebral Ischemia 
Cerebral ischemia is the result of lack of oxygenation to the brain due to a severe 
restriction of blood flow caused by either arterial occlusion or vessel damage. Ischemic 
strokes account for 87% of all stroke cases (22,23). Arterial occlusion can occur due to 
local cerebral thrombosis or from remote emboli which can block blood flow to the brain. 
The embolic occlusion typically originates from the chambers of the heart or the carotid 
artery.  
Oxygenation is required for the normal functioning of the mitochondria and the 
production of the neuronal cell‘s energy, Adenosine Triphosphate (ATP). Under ischemic 
conditions, the supply of ATP is quickly depleted and the cell can no long effectively 
maintain homeostasis. A vital consequence is the inability of the cell to power the ionic 
pumps that maintain ionic balance (24). The resulting ionic imbalance causes water to 
move down its osmotic gradient increasing the intracellular volume, resulting in cytotoxic 
edema. 
The amount of damage to the cerebral tissue can be described by the amount of 
residual cerebral blood flow (CBF) following infarction. With 50% reduction in blood 
flow, neuronal protein synthesis is reduced and progressively inhibited (CBF 
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<.55ml/g/min) (25). At lower blood flow, a switch from aerobic to anaerobic metabolism 
occurs (CBF < .35ml/g/min(25). At progressively more restricted blood flow, energy 
metabolism is disrupted (CBF < .2ml/g/min) and finally, anoxic depolarization occurs 
(.15ml/g/min) due to ionic imbalance from inability to maintain the ionic pumps. (25).  
The function of neurons also degrades as blood flow is restricted. A large range of 
thresholds for neuronal inhibition of functional activity exists, ranging from CBF  < 
.25ml/g/min to CBF < .15ml/g/min (25). A non-specific release of neurotransmitters 
begins to occur at CBF =.2ml/gm/min. 
1.3.2 The Ischemic Penumbra 
It is interesting to note in the above section that tissue can undergo a functional 
deficit without necessarily undergoing complete cellular depolarization. Tissue that has 
only a functional deficit without structural deficit (i.e., cytotoxic edema) may be able to 
be restored if the blood flow is increased (25). The definition of penumbra is the 
difference between cerebral tissue that has undergone irreversible cellular damage and 
tissue that has experienced low blood flow and some cellular functional changes (25-27). 
The penumbra is potentially salvageable if blood flow to the cerebral tissue was restored 
through pharmacological or surgical intervention. Typically, the core is in the center of 
the larger CBF deficit. The penumbral tissue is supported by collateral vessels which 
allow it to maintain its viability longer then the core tissue.  
The practical definition of penumbra is typically made through either MRI or 
Computed Tomography (CT) imaging. In the case of MRI, the penumbral volume is the 
difference in volume of tissue that is permanently infarcted, also called the stroke core, as 
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measured by diffusion weighted imaging (DWI) and the volume of tissue with reduced 
CBF as measured by perfusion weighted imaging (PWI). DWI is sensitive to the 
restricted motion of water. Due to the rapid influx of water into the cell corresponding to 
an ionic imbalance in severely ischemic cerebral tissue, water movement is severely 
restricted, creating contrast on DWI. In CT, the penumbra is defined by the difference 
between the CBF deficit and the Cerebral Blood Volume (CBV) deficit (28). Although 
cerebral tissue may have low CBF, auto regulatory mechanisms in salvageable cerebral 
tissue enable it to maintain adequate CBV (29). Once the CBV measurement is reduced, 
the tissue is said to be unsalvageable. The measurement of CT derived CBF and CBV is 
performed using bolus contrast chasing.   
It has been shown in both animal models of stroke and in human disease that 
cerebral tissue classified as penumbral does not maintain that status through the time 
course of the disease (7,30). Over time, the penumbral tissue changes to become part of 
the core (7). The goal of treatment, therefore, is to preserve the tissue in the penumbral 
area. 
1.3.3 Recombinant tissue Plasminogen Activator 
Recombinant tissue Plasminogen Activator (r-tPA) is currently the only Food and 
Drug Administration approved treatment for embolic ischemic stroke. r-tPA works by 
activating the fibrinolysis pathway to ultimately breakdown the embolus in the cerebral 
vasculature. r-tPA converts the inactive plasminogen to the active plasmin which 
ultimately performs the thrombolysis (31). The possibility of hemorrhage must be taken 
into consideration as it is a potential side effect of treatment. 
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Guidelines for the administration of r-tPA in light of the hemorrhage risk have 
been developed and are currently being reevaluated. The European Cooperative Acute 
Stroke Study (ECASS III) has suggested that the time window for administration of r-tPA 
should be extended to 4.5 hours following symptom onset (32). Other investigators have 
indicated that r-tPA administration should be based on imaging findings regardless of the 
time window (33).  
1.3.4 The no-reflow phenomenon 
One important aspect of thrombolytic therapy is the ‗no-reflow phenomenon‘ in 
which microcapillary blood flow is not fully restored even though complete 
recanalization of the occluded vessel occurs. Microcapillary damage is thought to 
accompany neuronal damage during ischemia (34). In ischemia, loss of the protective 
barrier between the blood and the neurons is damaged (34). Further, following ischemia, 
leukocyte adhesion molecules are expressed (34). Upon recanalization, this leads to 
recruitment of an immune response which serves to block microcapillary blood-flow (35). 
1.3.5 Experimental Rodent Models of Ischemic Stroke 
Two models of rat ischemic stroke have become popular in preclinical stroke 
pathophysiology characterization and treatment experimentation. The first procedure 
involves threading a suture through the internal carotid artery to the level of the middle 
cerebral artery, inducing a middle cerebral artery occlusion. In this model, reperfusion 
can be accomplished through withdrawal of the suture. The second procedure induces a 
middle cerebral artery occlusion via injection of an ex vivo created embolus through the 
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cerebral vasculature. Reperfusion can be achieved through the injection of a thrombolytic 
compound.  
A comparison of the two models performed by Henninger et al. reveals that the 
ischemic lesion is larger in the embolic model than the suture model (36). Further, the 
penumbral volume was larger and persisted longer in the embolic model (36). Finally, the 
embolic model produced more heterogeneous ischemic lesion volume than the suture 
model (36). 
1.3.6 MRI of Experimental Cerebral Ischemia 
Magnetic Resonance Imaging (MRI) of preclinical ischemic stroke in rats has 
been used to ascertain the response of brain tissue to recanalization by r-tPA and other 
thrombolytic compounds (37,38). The following section discusses the methods available 
for assessing the penumbral volume and determining the status of large vessel blood 
flow.  
1.3.6.1 Diffusion Weighted Imaging 
As mentioned earlier DWI is sensitive to infarcted cerebral tissue that has 
undergone electrical dysfunction and shifting of water from the extracellular to 
intracellular space. Much work has been performed in small animals to characterize the 
time course of volume changes of stroke core tissue. Much of that work has focused on 
characterizing the response of the stroke core to treatment. For example, in determining 
the efficacy of administration of r-tPA at different time points, Jiang et al. showed that 
treatment at 1 hour produced significantly lower infarct volumes in the treated groups as 
defined by DWI (39). Further, it has been shown through DWI that certain treatments can 
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halt the transformation of penumbral tissue into infarcted tissue. Bråtane et al., for 
example, showed that administration of granulocyte-colony stimulating factor during 
embolic stroke freezes the increase of permanently infarcted tissue volume (30).  
In order to facilitate quantitative analysis of permanently infarcted tissue, a 
threshold for infarction based on the ADC value was derived. As described in earlier 
sections, the ADC quantifies motion of water based on DWI images. In experimental rat 
stroke, Meng et al. defined permanently infarcted tissue as tissue in which the ADC falls 
below .53*10-3mm2/sec (40). This threshold has been used in subsequent experimentation 
and is well validated (30,36,37). 
1.3.6.2 Perfusion Weighted Imaging 
MRI based PWI is a method in which CBF can be calculated. CBF can be 
determined through two techniques, Arterial Spin Labeling (ASL) and Dynamic 
Susceptibility Contrast (DSC). The applications of these techniques to small animals will 
be discussed below. 
1.3.6.2.1 Arterial Spin Labeling 
Arterial Spin Labeling (ASL) is a PWI technique in which the inflowing blood is 
magnetically labeled using RF pulses. In small animals, much work has been performed 
using the continuous arterial spin labeling technique (CASL) which has been described in 
earlier sections of this chapter. CASL has been used extensively in experimental stroke 
imaging for definition of volume of tissue that experienced reduced CBF. Meng et al. 
determined that through the use of CASL, CBF must be less then .3ml/g/min in order for 
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the tissue to be considered ischemic (40). During rat permanent experimental ischemic 
stroke, the ischemic volume remains constant if not treated (41). The ischemic lesion 
volume as defined by CASL is rapidly reduced in the a suture reperfusion model of 
ischemic stroke (40). In the embolic model of ischemic stroke, r-tPA causes a slower 
reduction of the ischemic lesion (37). 
1.3.6.2.2 Dynamic Susceptibility Contrast 
Dynamic Susceptibility Contrast (DSC) is a method of measuring CBF  through 
the injection of a para- or ferro-magnetic contrast agent and observing the changes in the 
signal intensity derived from T2* weighted imaging. Typically, a gradient-echo, echo-
planar imaging sequence is used to allow for high temporal sampling during the bolus 
transit. The use of DSC has been utilized extensively in the literature (42-44). As 
compared to ASL, DSC is straight forward to implement, however, the measurement 
cannot be repeated in rapid succession due to the need for exogenously delivered contrast 
agents. Finally, threshold characterization of DSC derived relative CBF values for 
ischemia has not been performed.  
1.3.6.3 Time of Flight Angiography  
Time of Flight (TOF) angiography has been used to characterize the patency of major 
cerebral blood vessels in the brain. A high flip angle, short recovery time, short echo time 
pulse sequence is used to saturate the longitudinal magnetization of stationary tissue. 
Flowing spins, such as those in the blood, are not saturated and produce large transverse 
magnetization upon excitation. Thus, stationary tissue produces little signal while flowing 
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blood produces high signal. The application of TOF to the study of experimental stroke 
treatment has been rare. Hilger et al. has used TOF angiography to characterize 
reperfusion in an experimental rat stroke model (45). TOF produces excellent 
vessel/tissue contrast in areas of high, non-complex flow but may inaccurately 
characterize vessel patency if these conditions are not met. Both complex and low flow 
may increase the blood saturation due to the RF pulses causing a reduction in blood 
contrast.   
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1.4 Pulmonary Vascular Function 
The following section will describe vascular physiology in the lungs and the effects 
of pulmonary ischemia and alveolar hypoxia. MRI techniques used for quantitative 
imaging of pulmonary vascular function will be discussed along with their adaptations for 
preclinical imaging. This section will serve as background for chapter 5 and 6. 
1.4.1 Pulmonary Vasculature 
The major pulmonary artery (PA) is supplied directly from the right ventricle of 
the heart. Major pulmonary arteries are characterized by their elastic properties to 
accommodate varying blood flow with a corresponding changes in pressure (46). This 
maintains the low pressure of the system.  The major artery branches into smaller 
arterioles. These arterioles contain smooth muscle which undergo thinning as the vessels 
branch off closer to alveolar sacs (47). The arterioles feed capillaries which are fused to 
the surface of the alveolar sacs (47). The capillary interstitial space can be characterized 
as being either thin or thick (47). The thick interstitial space contains collagen fibers and 
other cellular elements such as fibroblasts and immune cells (47). Capillaries become 
venules which are similar in structure to the pulmonary arterioles (47). Finally, the 
venules branch away from areas of respiration into larger veins and eventually into the 
left atrium of the heart (47).  
1.4.2 Alveolar Gas Exchange 
Oxygenation of the blood is the primary function of the lung. The process of 
oxygenation of the blood involves two steps: 1.) transfer of the gas from the atmosphere 
to the alveoli, the site of gas exchange, and 2.) transfer of the gas from the lungs to the 
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blood. This process therefore involves both ventilation of gas and blood perfusion to the 
alveolar units. 
 The conductance of the air from the atmosphere to the alveoli is performed by 
branching airways which terminate at gas exchanging units known as alveoli. Gas 
exchange begins to occur 2-5 branches prior to the terminating alveolar sac (48). The 
alveolar wall is typically extremely thin and consists of an epithelium lining, a basement 
membrane, and an endothelial lining of a capillary. The thin wall is critical for efficient 
gas exchange from the air spaces to the blood (48). 
Oxygen diffusion from the airspaces to the blood is a passive process determined 
by concentration gradients between the airspaces and the blood. In the ‗ideal‘ scenario for 
efficient gas exchange a higher partial pressure of oxygen exists in the lung airspace, 
while a lower partial pressure of carbon dioxide exists in the blood. In this situation, 
oxygen diffuses into the blood and carbon dioxide diffuses into the airspace. A scenario 
may also exist in which the airspace has an equal or lower partial pressure of oxygen then 
that in the blood. In this situation, known as a shunt, no transfer of oxygen occurs. A final 
scenario may exist if no blood is flowing to the alveolar units which causes an increase in 
the partial pressure of oxygen in the effected airspace (49).  
1.4.3 Hypoxic Pulmonary Vasoconstriction 
The main function of the pulmonary vasculature is to match well ventilated areas 
of the lung with perfusion. A well studied phenomenon of the lung vasculature, known as 
hypoxic pulmonary vasoconstriction (HPV), constricts vessels to areas of lung in the 
condition of low alveolar partial pressure of oxygen (50). HPV plays an important role in 
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normal pulmonary function and in pulmonary disease. One of the most clinically 
prevalent examples of HPV occurs when patients expose themselves to areas of high 
altitude in which the partial pressure of oxygen in the atmosphere is reduced (51). HPV 
also occurs in obstructive diseases such as Chronic Obstructive Pulmonary Disease 
(COPD) and asthma. In these cases, areas of the lungs have reduced ventilation leading to 
regional reduction of the alveolar partial pressure of oxygen. In severe cases of COPD, 
HPV leads to chronic pulmonary hypertension which ultimately affects cardiac function 
(52-54). In a final example, HPV is an important consideration in the management of 
anesthesia. Specifically, patients often require single lung ventilation for the purposes of 
performing surgery which would be made difficult by the motion of the non-ventilated 
lung. Single lung ventilation results in a severe reduction of the partial pressure of 
oxygen to the alveoli units of the non-ventilated lung resulting in localized HPV. Certain 
anesthetic regiments ameliorate the HPV response, causing a shunt condition and 
ultimately hypoxemia (55,56). 
The site and molecular mechanisms underlying HPV are complex and not well 
understood. Current research indicates that the site of HPV occurs at the small pre-
capillary arterioles with some constriction occurring in the veins (57). It is currently 
thought that mitochondria housed within PA smooth muscle cells initiate a molecular 
response ultimately resulting in vasoconstriction (50). The molecular response is thought 
to be initiated by an increase in mitochondria reactive oxygen species (ROS) production, 
ultimately resulting in the activation of potassium membrane pumps and an increase in 
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intracellular concentrations of calcium, causing muscle depolarization and contraction 
(50,57,58).  
The long term effects of acute pulmonary hypoxia on pulmonary parenchyma are 
minimal. Edema formation has been shown to occur only after 24 hours of hypoxic 
exposure (59). Further, protein leak, a common occurrence in pulmonary vascular 
disease, is present only after exposure greater than 24 hours (59). Chronic hypoxia is 
associated with remodeling of the pulmonary arterioles and an inflammatory response 
(60,61). It is also interesting to note that during generalized hypoxia, such as seen at high 
altitudes, cardiac stroke work and carotid blood flow has been shown to increase owing 
to the increase in pulmonary vascular resistance (62). 
1.4.4 Pulmonary Embolism 
Pulmonary ischemia can occur as a result of an embolism which typically 
originates from thrombi in the extremities. The thrombi become dislodged and travel 
through the venous system ultimately lodging in the pulmonary arterial system. There are 
six hundred thousand new cases of pulmonary ischemia due to pulmonary embolism (PE) 
in the United States each year (63).  
PE can lead to a number of complications and has a high mortality rate when left 
untreated (63). PA occlusion results in high pulmonary circulation pressure. Increased PA 
pressure causes stress on the right ventricle which ultimately can lead to cardiac failure 
(64). Further, an immune response to PE has been shown in rat experimental models. 
Following one day of ischemia, neutrophils have been found in the right ventricle of the 
heart. During longer periods of embolism, macrophages have been localized to the right 
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ventricle (65,66). Ultimately, the presence of right ventricular dysfunction associated 
with PE results in poor clinical outcomes (64). 
PE does not cause pulmonary tissue damage as seen in other organs during 
ischemic disease, but does affect the lung‘s ventilatory processes. Pulmonary 
parenchymal tissue oxygenation is provided alternatively by the bronchial circulation and 
by the airways (46). In experimental models of PE, an increase in airway resistance and a 
decrease in pulmonary compliance have been shown (46).  
Treatment focuses on preventing future pulmonary thromboembolic events and 
not on the treatment of the acute PE except in cases of massive PE . Oxygen 
administration, anticoagulant therapy, and bed rest are standard treatments for non-
massive PE (64). Treatment can also include placement of a filter within the abdominal 
vena cava to prevent future emboli (64,67). Massive PE requires aggressive treatment 
including administration of thrombolytic therapy or mechanical embolus retrieval 
(68,69).     
1.4.5 Rodent Pulmonary Functional Vascular Imaging 
Quantification of pulmonary vascular functionality through imaging is important 
in clinical imaging of pulmonary disease. In the diagnosis of PE, for example, Single 
Photon Emission Computed Tomography (SPECT) is used to measure the capillary blood 
perfusion to lung tissue (70). In coordination with a SPECT pulmonary ventilation exam, 
a diagnosis of PE can be considered (64). Computed Tomography (CT) has emerged as 
the imaging modality of choice for visualization of the patency of the pulmonary arteries 
(71). MRI perfusion contrast bolus tracking has been used to quantify capillary blood 
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flow to the lungs and its usefulness in performing angiography has been demonstrated 
(72,73). 
Unfortunately, the advances in human pulmonary imaging have not translated into 
viable methodology for measuring pulmonary vascular function in rodents. Performing 
standard clinical imaging techniques for measuring pulmonary vascular function in 
rodents is made difficult by the necessity of high spatial and temporal resolution and by 
the faster rodent cardiac and respiratory rate. Development of techniques to measure 
pulmonary vascular function in rodents is important for studies of physiology, disease 
pathophysiology, and drug discovery. The following section describes attempts using 
various imaging modalities to measure pulmonary vascular function in rodents. 
1.4.5.1 Micro-CT 
Micro-CT operates on the same principle as clinically available CT imaging systems. The 
spatial resolution is sufficient to perform very detailed imaging of rodent anatomy. 
However, the temporal resolution is insufficiently high to perform standard contrast bolus 
tracking for angiography or blood perfusion measurements in rodents (74,75). Although 
there has not been much work in adapting micro-CT for rodent perfusion or angiography, 
Badea et al. introduced a method of staggered delivery of contrast agents for high spatial 
and temporal measurements of bolus perfusion (75).  
1.4.5.2 SPECT Perfusion Imaging 
In the clinic, perfusion imaging utilizing SPECT is performed using a long 
clearance radiotracer. Accumulation of the tracer in the capillaries of the organ of interest 
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indicates blood flow (70). Because of the steady state nature of this imaging protocol it is 
more readily translatable to imaging of small animals. Wietholt et al. introduced a 
SPECT system for small animal imaging and applied it to pulmonary perfusion imaging 
(76,77). Despite some success, the application of small animal SPECT to pulmonary 
perfusion imaging has been limited in the literature. Further, steady state SPECT 
perfusion imaging is semi-quantitative, making longitudinal studies difficult.  
1.4.5.3 Magnetic Resonance Imaging 
Proton MRI of pulmonary vascular function is hindered by low proton density, 
areas of high susceptibility resulting in very short T2* relaxation times, and cardiac and 
respiratory motion (78). These problems in rodents are amplified by the need for higher 
spatial and temporal resolution and by the increased cardiac and respiratory rate. 
Nonetheless, proton lung imaging methods have been developed for blood perfusion 
imaging of rodent lungs. Further, much work has been performed using HP gas imaging 
to measure vascular function.  
1.4.5.3.1 Proton MRI Techniques 
Proton MRI techniques of measuring pulmonary vascular function can be 
separated into two categories: steady state and dynamic imaging. The first, steady state 
imaging, involves injection of an intravascular contrast agent and measuring changes in 
the signal intensity of a T1 weighted image due to the contrast agent. The contrast agent 
used in many studies has been gadolinium-based and has typically consisted of a large 
molecular weight poly-l-lysine which has a slow rate of clearance and very little 
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extravascularization (79). These imaging protocols are very similar to SPECT perfusion 
scanning described previously. Spin echo with cardiac and respiratory gating or short 
echo time, and gradient echo projection-reconstruction imaging have been used to 
ameliorate the susceptibility issues inherent to lung tissue (79,80). The T1 signal intensity 
changes seen following contrast injection are based on a number of factors and cannot 
therefore result in a quantifiable measurement of vascular function.  
Little work has been performed in dynamic imaging of vascular function using 
MRI due to the interference of cardiac and respiratory motion. This measurement consists 
of injection of a gadolinium chelate while performing fast gradient echo T1 weighted 
imaging. The change in the signal intensity can be used to calculate pulmonary blood 
flow (PBF), pulmonary blood volume (PBV) and bolus mean transit time (MTT). Mistry 
et al. utilized scattered administrations of contrast agent following the detection of a 
cardiac R-wave similar to that adapted for micro-CT vascular imaging (81,82).  
1.4.5.3.2 Hyperpolarized Gas MRI Techniques 
HP-He can be administered to an animal and indicates areas of the lungs that are well 
ventilated. HP-He gas can also be used to indirectly detect pulmonary vascular 
functionality through the injection of contrast agent or through the monitoring of signal 
decay via oxygen relaxation (15-17,83-85). Both methods of imaging will be discussed 
below. 
Similar to proton MRI, interaction of HP-He with paramagnetic or ferromagnetic 
species hastens its transverse relaxation time. Due to the small distance between the 
capillary lumen and the alveolar airspace, injection of a paramagnetic or ferromagnetic 
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contrast agent will cause a reduction of the transverse relaxation time (85). This 
phenomenon can be used in a similar manner as that descried previously for proton MRI. 
Viallon et al. performed HP-He dynamic breath hold imaging while simultaneously 
injecting a ferromagnetic contrast agent (86). Following correction for flip angle HP 
magnetization destruction, the PBV was calculated. In a second application of perfusion 
imaging using HP gas and the injection of a contrast agent for perfusion quantification, 
the phase change of the HP-He signal was measured due to the presence of a 
paramagnetic contrast agent localized in the capillary network of the lung (85). The 
magnitude of the phase change is related to the concentration of the paramagnetic 
contrast agent present. These methods have the advantage of allowing for simultaneous 
ventilation and perfusion imaging. 
 In a second technique, the relationship between oxygen content and the rate of 
HP-He magnetization destruction can be utilized to measure the ability of the lungs to 
oxygenate the blood (15-17,83,84,87,88). During a breath hold, oxygen is continuously 
being up taken by the lungs in areas of normal perfusion. In areas of abnormal perfusion, 
oxygen remains in the airspace. A breath hold with both oxygen and HP-He results in 
destruction of the hyperpolarized magnetization proportional to the concentration of 
oxygen in the lungs (16). As oxygen leaves the air spaces, the rate of magnetization 
destruction is reduced. Accounting for RF flip angle magnetization destruction allows for 
the measurement of the initial partial pressure of oxygen and the oxygen uptake rate in 
the lungs. This methodology has been applied to a number of species and animal models 
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of disease (16,83,84). The details of the imaging protocol for this measurement is 
described in detail in chapter 5 of this dissertation.  
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 Chapter II: Gadolinium Based Contrast Perfusion Compared to 
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2.1 Preface 
In this work, we compare the definition of the ischemic lesion in rats using two 
Magnetic Resonance Imaging (MRI) methods: Dynamic Susceptibility Contrast (DSC) 
and Continuous Arterial Spin Labeling (CASL). We derived a threshold for ischemia as 
defined by DSC and used this threshold to make volumetric measurements of the 
ischemic lesion. The volume of this lesion was compared to the lesion volume as defined 
by ASL. Further, we analyzed the cerebral blood flow (CBF) time course in different 
ischemic stroke regions. My contributions to this work include experimental design, 
collecting and analyzing MRI data, and co-principle authorship of the manuscript. 
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2.3 Abstract 
Perfusion imaging is critical in imaging of ischemic stroke to determine ―tissue at 
risk‖ for infarction. In this study we compared the volumetric quantification of the 
perfusion deficit in two rat middle cerebral artery occlusion (MCAO) models utilizing 
two gadolinium based contrast agents (P1152, Guerbet and Magnevist®, Bayer-Schering) 
compared to our well established continuous arterial spin labeling (CASL) perfusion 
imaging technique. Animals underwent either permanent MCAO or transient MCAO 
with 80 minute reperfusion. Imaging was performed at four different time points post-
MCAO. A region of interest (ROI) analysis of subregions of the ischemic zone (core, 
penumbra, transient reversal (TR) and sustained reversal (SR)) utilizing P1152 showed a 
significant reduction in blood flow in the core and TR subregions relative to the 
penumbral and SR subregions while occluded. After reperfusion a significant increase in 
blood flow was recorded at all time points post-reperfusion in all regions except TR. 
From the ROI analysis the threshold for penumbra was determined to be -62±11% and 
this value was subsequently used for quantification of the volumetric deficit. The 
ischemic volume as defined by dynamic susceptibility contrast (DSC) was only 
statistically different from the CASL derived ischemic volume when using Magnevist® at 
post reperfusion time points. 
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2.4 Introduction 
With Magnetic Resonance Imaging (MRI), the ischemic penumbra can be 
approximated as the mismatch between the volume of the perfusion deficit and the 
volume of ischemic tissue injury as measured by Apparent Diffusion Coefficient (ADC) 
mapping (40,89). The characterization of this mismatch has implications clinically for 
identifying patients who might respond to acute therapies (90). Preclinical models of 
ischemic stroke in rats have shown that areas of penumbra ultimately are destined to 
become infarcted tissue without intervention (36,43,89). 
The perfusion deficit can be characterized by using a number of different 
methodological approaches. In one approach, an exogenous contrast agent, typically 
Gadolinium based, is injected intravenously (i.v.) and flows through the capillary system 
of the brain parenchyma (91). The presence of the agent causes a concentration-based 
change in both the longitudinal and transverse relaxation rates. Commonly, a dynamic 
single shot gradient echo sequence is performed to measure the contrast induced 
magnetic susceptibility (T2*) changes over time, which has been termed dynamic 
susceptibility contrast (DSC). This data can be used to define cerebral blood volume 
(CBV) and mean transit time (MTT), which can be combined to construct the cerebral 
blood  flow (CBF) as a function of voxel position (92). Quantification of the parameters 
is only possible when an arterial input function can be measured (93). 
In a second approach, the proton spins in the blood are magnetically labeled with a 
technique known as arterial spin labeling (ASL) (94). In the typical ASL imaging 
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sequence, the flowing spins in the blood are inverted or saturated. The contrast is 
produced as the magnetically labeled spins replace unlabeled spins in the cerebral 
vasculature, typically causing a reduction of signal in the areas of blood flow. This image 
is then subtracted from a control image in which labeling of the blood has not occurred. 
While a variety of methods exist to perform ASL, continuous ASL (CASL) has been 
shown by our group to accurately map the ischemic lesion (36,37,40,89). Preclinically, 
both contrast and ASL based MR perfusion measurements are used. Although thresholds 
have been derived to determine hypoperfused tissue for the CASL perfusion method, 
minimal work has been performed to derive such a threshold for the contrast enhanced 
perfusion method (41). Further, a comparison of the two methods for determining regions 
of hypoperfusion has not been performed. Therefore, in this study we examined perfusion 
deficits in permanent (pMCAO) and transient (tMCAO) middle cerebral artery occlusion 
models in rats using both the contrast enhanced and CASL methods of perfusion MRI. 
Changes in cerebral blood flow in ischemic stroke subregions as well as volumetric 
analysis of the perfusion deficit were determined. Based on CASL perfusion 
measurements, ADC mapping, and histology, we derived a contrast perfusion based 
threshold for identifying tissue at risk for ischemia and we further characterized relative 
cerebral blood flow (rCBF) values in ischemic subregions. In this work, we hypothesize 
that 1.) The temporal evolution of the rCBF is different in each stroke sub-region as 
characterized by DSC, 2.) A threshold for ischemia using DSC can be derived, and 3.) the 
volume of the ischemic deficit as determined by DSC is similar to that determined by 
CASL. 
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2.5 Methods 
All procedures used in this study were performed in accordance with our 
institutional guidelines. Spontaneously breathing male Wistar rats (n=20, Taconic Farms, 
Hudson, NY, USA) weighing 300±30g were anesthetized with isoflurane (5% for 
induction, 2% for surgery, 1.2% for maintenance) in room air. PE-50 polyethylene tubing 
was inserted into the femoral artery and vein. The femoral artery was used for monitoring 
the mean arterial blood pressure (MABP) and blood gases (pH, PaO2, PaCO2), 
electrolytes (Na+, K+, Ca2+), and plasma glucose levels. The femoral vein was used for 
i.v. bolus injection of the contrast agent. Body temperature was monitored continuously 
with a rectal probe and maintained at 37.0±0.3 °C with a thermostatically controlled 
heating pad. 
2.5.1 Middle cerebral artery occlusion 
Suture MCAO was performed as previously described in detail (95). Ten animals 
were subject to pMCAO using 4-0 silicone-coated nylon filament sutures, and ten to 
tMCAO using the in-bore reperfusion technique where the rats were mechanically 
reperfused by withdrawing the occluder at 80 minutes after MCAO while the animal was 
in the magnet (44). On the day of the experiment, rats were randomly assigned to receive 
either temporary or permanent MCAO. Further, data analysis was performed by an author 
blinded to the occlusion type and time point. 
2.5.2 DSC properties 
 In this study, P1152 (Guerbet) and Magnevist (Bayer-Schering) were utilized for 
DSC measurements. P1152 (Guerbet) is an investigational small molecular weight Gd 
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chelate compound with r1 longitudinal and r2 transverse relaxivities of 11.7 and 13.8 mM
-
1s-1 in water at 0.5 T, respectively. These values are significantly higher than those 
reported for conventional Gd chelates such as Gd-DTPA (Magnevist) or Gd-DOTA 
(Dotarem) (96). P1152 does not display any protein binding and shows a similar 
pharmacokinetic profile as Dotarem in anaesthetized rats with a blood half-life of 50 ± 7 
vs. 38 ± 2 min, a blood clearance of 6.9 ± 0.6 vs. 8.4 ± 0.8 ml/min/kg and a distribution 
volume of 322 ± 27 vs. 293 ± 6 ml/kg for both contrast agents respectively (unpublished 
Guerbet data). Magnevist and Dotarem are standard gadolinium chelates with comparable 
blood pharmacokinetics (97,98). 
2.5.3 Experimental protocol 
All 20 rats were imaged at the same time points (30, 60, 90, 120, 150, 180 and 
210 minutes) after MCAO. ADC and CBF maps derived from CASL were recorded at 
each imaging time point. For DSC, a contrast agent (P1152) was injected over ~1 sec at a 
dose of 0.1 mmol/kg followed by a saline bolus chaser (n = 12). DSC data were acquired 
every hour starting at 30 minutes (30, 90, 150 and 210 minutes). DSC data were also 
acquired in a subgroup of animals using Magnevist  at a dose of 0.1mmol/kg (n = 8). At 
24 h post-MCAO, brains were removed and sectioned coronally into seven 1.5 mm thick 
slices corresponding to the MR slices and stained with a 2% solution of 2,3,5-
triphenyltetrazoliumchloride (TTC) for 20 minutes at 37°. All histological analyses were 
conducted by an author who was blinded to the experimental protocol. 
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2.5.4 MRI measurements 
MRI experiments were performed on a 4.7 T/400 mm horizontal magnet equipped 
with a Biospec Bruker console (Billerica, MA), and a 2.0 G/mm gradient insert (inner 
diameter = 120 mm, rise time = 120 μs rise time). A surface coil (inner diameter = 23 
mm) was used for brain imaging with an actively decoupled butterfly neck coil for 
carotid blood spin labeling. Three diffusion-weighted images were separately acquired 
with diffusion-sensitive gradients applied along the x, y, or z direction. Single shot, spin 
echo echo-planar images were acquired over 2.5 minutes with matrix = 64 x 64, spectral 
width 200 kHz, TR 2 s (90° flip-angle), TE 37.5 ms, b = 8 and 1,300 s/mm2, Δ = 24 ms, 
δ = 4.75 ms, field of view 25.6 x 25.6 mm, seven 1.5 mm slices, and 16 averages. The 
total acquisition time was 2 minutes and 4 seconds. 
 Quantitative CBF measurements were made using the CASL technique with 
single-shot, gradient-echo, echo-planar images acquisition. Sixty paired images (for 
signal averaging) were acquired over 4 minutes, alternately; one with and the other 
(control) without spin labeling preparation. The MRI parameters were similar to ADC 
measurements except TE = 13.5 ms. The labeling pulse utilized a 1.78-second, square 
radiofrequency pulse in the presence of 1.0 Gauss/cm gradient along the flow direction. 
The sign of the frequency offset was switched for non-labeled images. DSC 
measurements were performed using an echo planar gradient echo imaging sequence with 
a TR of 1 s, TE of 15 ms, and flip angle of 90°. The field of view was 25.6 mm x 25.6 
mm with a matrix size of 64 x 64. Ten dummy scans were conducted to reach a steady 
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state and contrast injection occurred after 25 acquisitions The total acquisition time was 
1.5 minutes. 
2.5.5 ADC and Quantitative CBF Mapping 
Diffusion weighted and CASL perfusion images were analyzed using QuickVol II 
(http://www.quickvol.com/). Quantitative CBF and ADC maps and their corresponding 
threshold-derived lesion volumes were calculated as described previously (41). Assuming 
a blood-brain partition coefficient, λ, of .9, tissue T1 of 1.5 seconds, and inversion 
efficiency, α, of .75 the blood flow in terms of ml/g/tissue can be calculated by: 
    
        
               
                                                      [2.1] 
where Sc and SL are the control and labeled images, respectively. ADC maps were 
calculated through the methods described in section 1.1.10.2. 
The thresholds used to define respective abnormal ADC and CBF regions were a 
reduction to 0.53 x 10-3 mm2/s and reduction of 57 ± 11% respectively (41). ADC and 
CBF data that met that threshold were considered infarcted and ischemic, respectively. 
2.5.6 Derivation of regions of interest  
Four subregions in the ischemic zone were investigated. To locate these regions, 
ADC and CASL maps were compared to 24 h histology by coregistration of the imaging 
derived pixels on the corresponding TTC pixels. The ischemic core was defined as 
abnormal by the previously determined threshold on the ADC maps and infarcted tissue 
on the 24h histology. The penumbra was defined as abnormal on the CASL map using 
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the previously determined threshold but was not abnormal on the ADC map at 30 min 
post MCAO. Transient and sustained recovery (TR and SR) were both regions with a 
deficit on the ADC map at 30 min, but with normalization of that region on the ADC map 
after reperfusion. In the SR region the 24 h histology did not show infarction whereas in 
the TR region the 24 h histology did show infarction. TR and SR were only found in the 
tMCAO group. A graphical description of the four regions of interest (ROI) is given in 
Figure 2.1. The ROIs were manually outlined based on the criteria described in this 
paragraphy using QuickVol II. 
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2.5.7 Derivation of rCBF from DSC Data 
Curves from contrast enhanced perfusion images and ROI data were fit to a 
modified gamma variate which allows for simplified fitting of first pass data 
implemented using Matlab (Mathworks, Natick, MA) software (99). Briefly, the first pass 
of a bolus contrast can be described as a gamma variate function given as 
           
 
 
                                                                    [2.2] 
where α and β are shape and scale parameters and A is the amplitude of the change in 
bolus concentration (99). While fitting DSC to this equation can be performed using non-
linear techniques, Madsen describes a method in which the equation can be linearized to 
Figure 2.1 Schematic representation of subregions within an ischemic stroke. CBF deficits represent the 
total region that will be infarcted at 24h with no intervention. ADC deficits represent regions that are 
affected early after MCAO. The mismatch between CBF and ADC is referred to as ischemic penumbra 
(yellow). Sustained Recovery (SR, green) is the part of this recovery that ended up as healthy tissue on 
histology at 24h in contrast to Transient Recovery (TR, blue) that was incorporated in the ischemic stroke 
at 24h histology. Core (red) is the diffusion lesion that did not reverse with intervention. 
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allow for more simplified fitting (99). The gamma variate fit allowed for determination of 
the relative cerebral blood volume (rCBV), relative mean transit time (rMTT), which 
were used to construct the rCBF maps as 
     
    
    
 
    
   
    
    
                                            [2.3] 
where ∆R2
*
 is the change in transverse relaxation rate and t is the time following bolus 
arrival. The term relative indicates that deconvolution with an arterial input function was 
not performed (93). rCBF values were reported as percent changes in rCBF between the 
ipsi- and contralateral regions as previously described (92). A threshold for ischemic 
tissue was derived by averaging the rCBF in the penumbral area at all time points in the 
pMCAO group and at the 30 min time point in the tMCAO group. Volumetric analysis of 
the rCBF based perfusion deficit was identified by a combination of the derived threshold 
and visual inspection. 
2.5.8 Statistical analysis 
Data are presented as mean ± standard deviation unless stated otherwise. Statistical 
comparisons were performed using ANOVA with post hoc Bonferroni test, Mann-
Whitney U, and Wilcoxon Signed Ranks Test, where appropriate. Calculations were 
performed using SPSS (v15.0, Chicago, USA). P<0.05 was considered significant. 
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2.6 Results 
There were no between group differences in regard to physiological parameters 
(MABP, blood gases, electrolytes) (Appendix I). To illustrate a typical pMCAO and 
tMCAO animal, representative images of each image modality (ADC, CASL, and DSC) 
and histology are presented in Figure 2.2.  
 
2.6.1 Region of interest analysis 
A ROI analysis was performed in order to characterize the temporal changes in 
the ischemic subregions (core, penumbra, TR and SR). Based on the DSC imaging with 
the contrast agents rCBF data were derived from each of the subregions (see Figure 2.3). 
In animals subjected to pMCAO, rCBF in the ischemic core and penumbra was 
depressed. This observation persisted over all time points. In the tMCAO group, 
Figure 2.2 Representative images of an A) ADC map, B) CASL derived rCBF map, C) DSC derived rCBF 
map, and D) TTC in a pMCAO (top row) and tMCAO (bottom row) model of ischemic stroke. Note that 
the perfusion-weighted image in the tMCAO model was recorded post reperfusion.  All MR images were 
recorded 90 minutes post MCAO and TTC was performed at 24 hours post MCAO. 
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significant increases in rCBF were found at all time points following reperfusion as 
compared to the pre-reperfusion time point for both core and penumbra regions. The 
post-reperfusion time points also had significantly increased rCBF compared to the same 
time points in the pMCAO model. A significant increase in rCBF was also found 
between pre- and post-reperfusion time points in the SR region. Statistical differences in 
rCBF during ischemia were also found between the four subregions. Core and TR region 
were found to have significantly lower rCBF as compared to penumbra and SR region at 
the initial time point (see table 2.1). Based on DSC derived penumbral blood flow using 
P1152 during ischemia, an rCBF threshold of -62±11% was derived.  
Figure 2.3 Time course of rCBF differences between the ipsi- and contralateral side in the A) core, B) 
penumbra, C) transient recovery and sustained recovery subregions as measured by P1152. *Significant 
increase in rCBF compared to 30min tMCAO ^ significant increase in rCBF compared to 90min tMCAO. # 
indicates the 80 minute reperfusion time point. P<0.05. 
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 Stroke Regions 
Stroke Region Core Penumbra Sustained 
Reversal 
Transient 
Reversal 
Core NA 0.005* 0.007* 0.984 
Penumbra 0.005* NA 1 0.023* 
Sustained Reversal 0.007* 1 NA 0.006* 
Transient Reversal 0.984 0.023* 0.006* NA 
Table 2.1 Significance levels of rCBF in ischemic subregions as determined by DSC during occlusion of 
animals subjected to MCAO. *p < 0.05. 
 
2.6.2 Spatiotemporal evolution of the perfusion modalities 
Figure 2.4A shows perfusion lesion volume evolution over time for CASL and 
P1152 derived DSC measurements in the pMCAO and tMCAO models. At each time 
point, no statistically significant volumetric difference was found between the perfusion 
lesion volume measured by CASL and contrast perfusion based rCBF as measured by 
P1152. As expected, in the pMCAO model, the volume of the perfusion deficit remained 
constant as shown by both the CASL and DSC techniques. As expected, the perfusion 
lesion volume in the tMCAO model revealed a large initial deficit with a rapid decrease 
following the 80 minute reperfusion. This decrease in hypoperfused volume was 
statistically significant compared to the pMCAO time point for both CASL and P1152. 
To evaluate the generalizability of the P1152 DSC derived perfusion data, 
perfusion measurements were performed in a group of animals with Magnevist and 
CASL. Similar to the results obtained with P1152, no statistical significant differences 
were found between the perfusion lesion volumes as measured by CASL and Magnevist 
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DSC in animals subjected to pMCAO. However, the lesion volumes were significantly 
overestimated by Magnevist DSC in tMCAO animals as compared to CASL following 
reperfusion. The perfusion deficit derived from Magnevist DSC showed a similar 
temporal perfusion lesion volume evolution as that with P1152 (see Figure 2.4B). 
  
Figure 2.4 Volumetric analysis of the perfusion deficits in the pMCAO and tMCAO model. A) P1152 vs 
CASL and B) Magnevist vs CASL. Note the persistent perfusion lesion volume over time in the pMCAO 
groups and the large drop in the perfusion lesion volume following reperfusion in the tMCAO groups. 
*Significant reduction in lesion volume compared to pMCAO time point for both CASL and DSC 
perfusion. **Significant increase in lesion volume compared to CASL perfusion. .#indicate the 80 minute 
reperfusion time point. P<0.05. 
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2.7 Discussion 
 Our results presented here demonstrate that DSC based relative perfusion 
measurements can potentially be used to monitor different regions of ischemic tissue in a 
preclinical model of stroke. Our results characterizing the time course of rCBF in 
ischemic subregions in both transient and permanent MCAO models of stroke are 
consistent with previously published results on spatial-temporal changes in blood flow as 
measured by CASL (36,89,100). 
Results from animals subjected to tMCAO showed a statistically significant 
increase in rCBF in areas of core and penumbra compared to pre-reperfusion values. 
Areas of SR and TR also show an increase in blood flow from pre-reperfusion time 
points. The increase in rCBF as measured by P1152 in areas of SR following reperfusion 
reached significance, however, areas of TR did not. Lack of statistical significance may 
be due to the relatively small number of animals available displaying areas of TR and to 
the high inter-animal variability of the data. 
Our results are consistent with previous work. In animals subjected to 35 minutes 
of MCAO followed by reperfusion, Bardutzky and colleagues reported that voxels which 
were characterized as being in the ischemic core during occlusion experienced an 
increase in rCBF following reperfusion (89). Despite different ultimate tissue fate, blood 
flow restoration was similar for each identified subregion (core, penumbra, SR, TR). This 
is similar to our results with the exception of the TR region where blood flow is more 
heterogeneous and tends to have a large initial overshoot in rCBF recovery followed by a 
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decline. In penumbral regions, we showed a moderate increase following reperfusion that 
leveled off at later time points. This is also similar to the results reported by Bardutzky 
and colleagues. 
Interestingly, the initial values of rCBF for areas of SR were higher than those for 
TR. We also observed that penumbral regions had a significantly higher rCBF than both 
core and areas of TR. While a number of factors play a role in the recovery of tissue post-
ischemia, the amount of remaining perfusion certainly plays a major role in tissue 
preservation (89). Our data suggest that careful analysis of the blood flow in the ischemic 
region as defined by ADC suppression may provide clues as to the extent of infarction 
recovery upon recanalization.  
 Based on our ROI analysis, we were able to derive a threshold value of -62±11% 
for the determination of ischemic tissue based on DSC derived rCBF. This threshold is 
slightly lower than the established threshold of a 57 ± 11% reduction of CBF for 
ischemic tissue as derived by CASL (41). This difference may be explained by the fact 
that quantitative CBF measurements in ASL techniques are highly dependent on the 
transit time of the labeled spins. Longer transit time, as is the case in ischemic stroke, 
causes longitudinal relaxation of the spins and may lead to underestimation of the blood 
flow in regions of low flow. In the case of longer transit times, the difference in signal 
intensity of the labeled images versus the control images would be smaller, resulting in 
an underestimation of the blood flow.  Further, gradient echo based DSC measurements 
have been shown to overestimate the blood flow in areas of volume averaged large 
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vessels and tissue. (101). Given the spatial resolution, it is likely that some cerebral 
parenchyma voxels are partial volume averaged with large vessels. This would serve to 
increase the magnitude of the rCBF reduction between ischemic and normal tissue. 
Nevertheless, the threshold derived here for rCBF measurements can be used for 
quantitative analysis of the volumetric perfusion deficit in experimental stroke models. 
The derived threshold should be considered in light of the experimental technique used to 
acquire the data set. Contrast administration methodology and MR imaging parameters 
such as recovery and echo times can affect the derived threshold. Laboratories attempting 
to undertake contrast based MR perfusion measurements as the main modality for 
determining perfusion deficit in preclinical stroke models are encouraged to derive 
thresholds relevant to their contrast administration and imaging techniques. 
 Our DSC based volumetric analysis of the perfusion lesion in pMCAO and 
tMCAO models of stroke correlates well with the previously established CASL 
volumetric analysis. Moreover, there was no statistically significant difference between 
the volumetric analysis derived by DSC using P1152 and CASL. The volumetric 
measurements as derived by DSC matched well with the time course defined previously 
(40,42,89). While results demonstrated a similar temporal evolution of lesion volume 
between Magnevist and P1152 derived measurements, Magnevist derived data 
overestimated the perfusion deficit as compared to CASL in animals subjected to 
tMCAO. This is not entirely unexpected as areas on the border of tissue that remained 
ischemic and tissue that is fully reperfused may not be well characterized by Magnevist 
as compared to P1152 due to its lower relaxivity. 
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 These results lend credence to the use of DSC with P1152 to evaluate penumbral 
lesion volume in preclinical models of ischemic stroke. Although CASL offers many 
advantages over DSC based perfusion measurements, it suffers from more complex 
implementation from a hardware perspective. Transit time in rats from the spin labeling 
location (i.e. carotid arteries) to the brain parenchyma is rapid on the time scale of the 
longitudinal recovery rate of the blood magnetization. This is not the case in ischemic 
stroke where the transit time is increased (93). We have shown that contrast perfusion can 
be used to accurately measure the perfusion deficit in stroke. Due to its ease of 
implementation and the wide availability of contrast materials, it represents a viable 
alternative to CASL imaging in stroke in rats and perhaps clinically for perfusion deficit 
volume measurements. One of the main weaknesses of contrast enhanced methods from 
an imaging point of view is contrast retention in the blood causing 1.) a second pass 
phenomenon and 2.) a lack of rapid repeatability of perfusion measurements (102). The 
impact of the first issue has been addressed by fitting the data to a gamma variate 
function. Fitting this data set can be performed using non-linear least square fitting to a 
gamma variate model. Alternatively, a simplified form of the gamma variate, which was 
utilized in this study, allows for linear fitting of the data. One difficulty that has been 
pointed out for both approaches is the identification of the bolus arrival time, which can 
be particularly problematic in regions of low blood flow where the bolus arrival time may 
be indistinguishable from the baseline data. Automated detection schemes have been 
proposed to find the arrival time but all require clear delineations between the trend of the 
baseline and the bolus (103).  
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 It is interesting to note that we were able to conduct these experiments using the 
same molarity per kilogram body weight of P1152 and Magnevist as typically 
administered in clinical procedures for standard contrast agents. In other similar animal 
studies, double and triple doses of Magnevist and other compounds are administered to 
be able to adequately characterize the rCBF (93,104).  
 A limiting factor for the ROI analysis is the small number of tMCAO animals that 
had TR regions that could be analyzed. The analysis of the TR and SR regions were not 
the primary goal of this study and should therefore be considered exploratory. 
In conclusion, in this investigation, we have shown that MRI paramagnetic 
contrast agent based perfusion measurements reveal different blood flow changes within 
ischemic subregions. Further, we showed that ischemic lesion volume determination 
based on contrast perfusion measurements was not different as compared with CASL 
derived ischemic region volumes. High relaxivity contrast agents like P1152 may be 
more appropriate for measuring blood flow in certain ischemic subregions.  
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3.1 Preface 
MR visualization of clots can contribute to the overall utility of preclinical stroke 
research. There has been a recent push to derive new lytic compounds and compounds 
that augment tissue Plasminogen Activator (tPA). We have developed a method of 
labeling clots for MRI and histological visualization of in vitro clots injected in rats to 
cause an ischemic stroke. We have used this technique to test the effectiveness of 
recombinant Annexin II (rA2), a compound thought to increase the effectiveness of tPA. 
My contributions to this work include in vitro experimentation, experimental design, 
collecting and analyzing MR data, and co-principle authorship of the manuscript. 
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3.3  Abstract  
Objectives: The purpose of this study was to develop a novel MRI method for imaging 
clot lysis in a rat embolic stroke model, and to compare tissue plasminogen activator  
(tPA) based clot lysis with and without recombinant Annexin-2 (rA2). 
Methods: Experiment 1: In vitro optimization of clot visualization using multiple MRI 
contrasts agents in concentrations ranging from 5 to 50µL in 250µL blood. Experiment 2: 
In vivo characterization of the time course of clot lysis using the clot developed in the 
previous experiment. Diffusion, perfusion, angiography, and T1-weighted MRI for clot 
imaging were conducted prior to and during treatment with vehicle (n = 6), tPA (n = 8) or 
rA2+tPA (n = 8) at multiple time-points. Brains were removed for ex vivo clot 
localization. 
Results: Clots created with 25µL Magnevist© were the most stable and provided the 
highest contrast-to-noise ratio. In the vehicle group, clot length as assessed by T1-
weighted imaging correlated with histology (r = 0.93). Clot length and CBF-derived 
ischemic lesion volume were significantly smaller than vehicle at 15 minutes post-
treatment initiation in the rA2+tPA group, while in the tPA group no significant 
reduction from vehicle was observed until 30 minutes post-treatment initiation. The 
rA2+tPA group had a significantly shorter clot length than the tPA group at 60 and 90 
minutes post-treatment initiation, and significantly smaller CBF deficit than the tPA 
group at 90 minutes post-treatment initiation.  
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Interpretation: We introduce a novel MRI based clot imaging method for in vivo 
monitoring of clot lysis. Lytic efficacy of tPA was enhanced by rA2. 
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3.4 Introduction 
Previous studies in experimental stroke models demonstrated that tissue 
plasminogen activator (tPA) mediated recanalization and subsequent reperfusion leads to 
reduced final infarct volumes (37,105,106). Currently available magnetic resonance 
imaging (MRI) methods to determine arterial patency such as time of flight angiography 
(TOF) in small animals are sensitive to a number of parameters including flow, blood 
longitudinal relaxation time, and sequence parameters (107). Signal intensity is based on 
a combination of these parameters and may make quantitative analysis of thrombolysis 
difficult. This might explain why a relationship between recanalization and reperfusion 
has not been clearly established (45). Direct clot imaging has been proposed, but these 
techniques typically require a multimodality approach or targeted contrast agents not 
readily available to investigators (108-110). Though in vitro assays are available to test 
the effects of thrombolytics on blood clots, these systems cannot sufficiently mimic the in 
vivo environment (111). Direct in vivo MRI-based visualization of the embolus will allow 
for near real time quantification of clot dissolution and provide unique information 
regarding lytic efficacy of thrombolytic agents. 
In this study, we present a novel MRI methodology for clot visualization in an 
experimental stroke model using a commercially available contrast agent. Further goals 
of this study were to characterize clot lysis dynamics during thrombolytic therapy and to 
evaluate the lytic efficacy of tPA with or without recombinant Annexin-2 (rA2), a 
compound thought to enhance the lytic action of tPA (105). We hypothesize that 1.) clot 
visualization with MRI is possible via the addition of contrast agent to the blood prior to 
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formation, 2.) the clot length as measured by MRI is representative to that measured ex 
vivo, 3.) MRI based clot visualization is useful in visualization of clot lysis, and 4.) MRI 
based clot visualization is sensitive to the efficacy of different lytic agents. 
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3.5 Materials and Methods 
This study consisted of two experiments. The first (in vitro) experiment involved 
designing a robust method for modifying standard clots for visualization on MRI and 
histology. The second (in vivo) experiment characterized the temporal evolution of clot 
lysis mediated by tPA vs. tPA combined with rA2 (rA2+tPA) utilizing MRI. 
3.5.1 In vitro experiment (Experiment 1) 
Briefly, clots were formed by as follows: 200uL of blood was withdrawn from the 
tail artery and mixed with 4.5uL of 1 mol/L calcium chloride and 1.0 National Institutes 
of Health (NIH) units of human thrombin.  A portion of the mixture was drawn into a 
30cm polyethylene catheter (PE-50) and was allowed to clot for 2 hours at 37°C for 2 
hours. Following this period, the clot was ejected from the tubing into a 2% Evans Blue 
(EB) solution and stored at 4°C for 24 hours (112).  These clots were modified by mixing 
250 µL of blood with four different contrast agents at volumes of 0uL, 5uL, 10uL, 15uL, 
20uL, 25uL, and 50uL to blood prior to clotting to determine optimal contrast agent type 
and volume for MRI visualization. The contrast agents used were Magnevist© (Berlex 
Laboratories, Montville, NJ, USA), Combidex© (Combidex Threading Tools b.v, Nieuwe 
Waterwegstraat 5, Schiedam, Holland), Omniscan© (GE Health Care, Princeton, NJ, 
USA) and Eovist© (Bayer Healthcare Pharmaceuticals, Wayne, NJ, USA). An animal 
surgeon with experience in embolic stroke modeling inspected the quality of the clots. At 
the contrast volumes used, Magnevist© infused clots showed consistent stability, while 
the use of the other contrast agents resulted in fragile and unstable clots. Magnevist© was 
therefore used for the in vitro and in vivo experiments. 
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For in vitro quantification of contrast intensity Magnevist© clots were placed in 
saline and imaged using the T1-weighted imaging (T1WI) sequence described in the MRI 
section. The resulting signal intensity of the clot and surrounding saline was measured. 
The clot enhancement ratio was calculated by dividing the clot signal intensity by the 
saline signal intensity.  
3.5.2 In vivo experiment (Experiment 2) 
All procedures used in this study were approved by University of Massachusetts 
Medical School Institutional Animal Care use Committee. Spontaneously breathing male 
Wistar rats (n = 22, Taconic Farms, Hudson, NY, USA) weighing 318 ± 27 g were 
anesthetized with isoflurane (5% for induction, 2% for surgery, 1.2% for maintenance) in 
room air. PE-50 polyethylene tubing was inserted into the femoral artery for monitoring 
of mean arterial blood pressure (MABP), blood gases, electrolytes, and glucose. 
Additional tubing was inserted into the femoral vein to allow for intravenous (i.v.) 
infusion of tPA, rA2+tPA, or vehicle. Body temperature was monitored continuously 
with a rectal probe and maintained at 37.0 ± 0.5°C with a thermostatically controlled 
heating pad. Embolic stroke (ES) was induced in all 22 animals. Briefly, the ES was 
induced by temporarily occluding the common carotid artery and catheterizing the 
external carotid artery. The external carotid artery catheter was advanced to the base of 
the skull via the internal carotid artery and a 18mm clot was injected (112). The animals 
were randomly assigned to either vehicle (n = 6), tPA (n = 8) or rA2+tPA (n = 8) 
treatment. The i.v. infusion of thrombolytics or vehicle was administered at 90 minutes 
following ES with a 10% bolus and the remainder infused over 1 hour. The vehicle group 
79 
received 1 mL of saline, while the tPA groups received 10 mg/kg tPA dissolved in either 
1 mL of saline or rA2 solution (5 mg/kg). Histidine tagged rA2 was produced in E. coli 
from a bacterial expression vector containing full-length human annexin-2 
complementary DNA according to the method previously described (113). Purity of rA2 
was confirmed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) followed by Coomassie blue staining, and its identity was verified by western 
blot analysis. rA2 was finally eluted and kept in elution buffer (20 mM sodium 
phosphate, 0.5 M NaCl, 500 mM imidazole, pH 7.4). Imaging was performed from 30 to 
180 minutes and animals were electively sacrificed at 3.5 hours after ES to remove their 
brains. Brains were imaged using an optical scanner and EB stained clots were identified 
and their lengths measured. 
3.5.3 MRI 
MRI experiments were performed on a Bruker system utilizing a 4.7 T/40 cm 
horizontal magnet equipped with Paravision software (Billerica, MA), and a 20G/cm 
gradient insert (ID = 120 mm, 120 μs rise time). A surface coil (ID = 23 mm) was used 
for brain imaging and an actively decoupled neck coil for perfusion labeling (40). T1WI 
and perfusion weighted images (PWI) were acquired at 60, 90, 105, 120, 135, 150 and 
180 minutes post-ES. Diffusion weighted imaging (DWI) was acquired at 30, 90, and 160 
minutes post-ES. TOF magnetic resonance angiography (MRA) was performed at 60 and 
150 minutes post-ES. PWI, DWI and MRA were performed as previously described in 
detail.(112) Two contiguous slices with in plane visualization of the bifurcation of the 
middle cerebral artery (MCA), anterior cerebral artery (ACA), and internal carotid artery 
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(ICA) were recorded sequentially using a T1WI centric ordered turbo spin echo with a 
echo train length of 4, an echo time of 3.2 ms, a recovery time of 290 ms, a field of view 
(FOV) of 2.56 x 2.56 cm, a slice thickness of 750 µm, and a matrix size of 256 x 128. 
Saturation slabs 1 cm thick were placed posterior and anterior to the Circle of Willis to 
reduce flow induced imaging artifacts. 
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3.5.4 Analysis of MRI data 
A maximum intensity projection image (MIP) was created from the two T1WI 
slices acquired, and analyzed using the Medical Image Processing, Analysis, and a 
Visualization software package (NIH, mipav.cit.nih.gov). To identify the clot on the MIP 
of the T1WI, a ≥ 30% signal intensity within the ICA, MCA, and ACA compared to the 
surrounding brain parenchyma was chosen. An investigator (RPW) blinded to treatment 
assignment outlined the clots using the software‘s tracing tool. The length of the clot in 
each vessel was summed and the total clot length during and after treatment was reported 
as a percentage of the initial clot length. 
DWI, PWI and MRA were analyzed blinded to treatment assignment using 
QuickVol II (http://www.quickvol.com/) (114). Quantitative apparent diffusion 
coefficient (ADC) and cerebral blood flow (CBF) maps were created and their 
corresponding threshold-derived lesion volumes were calculated as described previously 
(40,114). The thresholds used to define respective abnormal ADC and CBF regions were 
a reduction to 0.53 x 10-3 mm2/s and 0.3 mL/g/min, respectively, as previously 
validated.(40) Diffusion and perfusion lesion volumes are expressed as percentages of the 
initial volumes at 30 (DWI) and 60 (PWI) minutes, respectively. 
For comparative purposes, MRAs were visually analyzed by a blinded 
investigator (KMS) and were scored on a 3 point scale as follows: 3 = complete MCA 
occlusion, 2 = partial MCA reperfusion and 1 = complete reperfusion of the MCA. MCA 
was selected for analysis to reveal an overall picture of vessel recanalization. 
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3.5.5 Analysis of Evans Blue Clot Histology 
The entire surface of all the rat brains was scanned with a high resolution (1600 dpi) 
scanner. The EB clot was identified, and measured by summing the length of all clot 
fragments. Total clot length was assessed and correlated with MRI to validate T1WI-
derived clot length and to determine the lytic efficacy of each treatment.  
3.5.6 Statistics 
Data are presented as mean ± standard deviation. Statistical comparisons were performed 
using one-way Analysis of Variance (ANOVA) with post hoc Least Significant 
Difference (LSD) test for multiple comparisons. Correlation analysis was performed 
using Pearson two-tailed test (Version 15.0, SPSS Inc., Chicago, IL, USA). p<0.05 was 
considered significant. 
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3.6 Results 
3.6.1 In vitro clot experiments  
Figure 3.1 shows a Magnevist© enhanced clot suspended in saline. The clot‘s signal 
enhancement ratio was calculated for concentrations ranging from 0 µL to 50 µL of 
Magnevist©. Signal enhancement was undetectable in clots with the lowest contrast agent 
volumes of ≤ 5 µL. Table 3.1 displays the clot‘s signal enhancement ratios at various 
Magnevist© volumes. The 25 and 30 µL Magnevist© volume provided significantly 
higher signal enhancement ratios relative to all other concentrations used, with 
insignificant differences between these two concentrations.  
 Contrast Concentration 
 0 µL 5 µL 10 µL 15 µL 20 µL 25 µL 30 µL 50 µL 
Enhancement 
Ratio 
0 0 1.28±0.04 1.26±0.06 1.32±0.09 2.1±0.10# 1.88±0.15# 1.45±0.22 
Table 3.1 In vitro clot enhancement ratios 
We opted to use 25 µL Magnevist© in all further experiments to obtain the highest clot 
signal enhancement ratio while utilizing the lowest contrast agent volume. 
Figure 3.1 Maximum intensity projection of Magnevist© (25 µL 
contrast agent in 250 µL blood) infused clots suspended in saline 
utilizing T1-weighted imaging. Arrows point to clot sections. 
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3.6.2 In vivo clot experiments 
The Magnevist©/EB-modified clots were visible on MRI and histology. They produced 
consistent arterial occlusion and subsequent ischemic changes as assessed by T1WI, 
PWI, DWI and MRA in all animals. 
When exposed to tPA the clot 
slowly dissolved over 90 minutes 
after treatment initiation. In both the 
vehicle and the tPA group, T1WI 
results matched well with EB 
stained clot found in the MCA, 
ACA and ICA post mortem (Figure 
3.2). T1WI-derived 180-minute clot 
length correlated significantly with 
the clot length assessed on histology (r = 0.93, p < 0.05). Figure 3.3 shows a scatter plot 
of histologically and MRI derived clot lengths.  
Figure 3.2 In vivo Maximum Intensity Projection of the clot utilizing T1-weighted imaging in a 
representative vehicle (top) and tPA (bottom) treated animal, respectively. Note the progressive clot lysis 
in the tPA-treated but not the vehicle animal. T1-weighted imaging results match well with Evans Blue 
(EB) stained clot found on histology 3.5 hours post embolization. Arrow 1, 2 and 3 points to clot visible in 
anterior cerebral artery, internal carotid artery, and middle cerebral artery respectively.  
 
Figure 3.3 Histologically versus MRI Derived Clot Length 
measures. r=.93, p<.05 Note: Regression Line Shown  
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3.6.3  MRI experiment 
Initial clot localization was determined in all animals before treatment was 
initiated. Clot localization was as follows: MCA + ICA + ACA (n = 13 (59%)), ICA + 
ACA (n = 4 (18%)), ACA + MCA (n = 3 (14%)), and ICA + MCA (n = 2 (9%)), 
respectively. MABP, blood gases, electrolytes, and glucose were not significantly 
different between groups, and values remained within physiological limits throughout the 
study (Appendix II). 
Clot length and CBF lesion volumes were significantly smaller than vehicle at 15 
minutes post-treatment initiation in the rA2+tPA group, while in the tPA group no 
significant reduction from vehicle was observed until 30 minutes post-treatment 
initiation. Beginning at 60 minutes post-treatment clot length in the rA2+tPA group was 
significantly smaller than in the tPA group. From 90 minutes post-treatment initiation, 
CBF lesion volume in the rA2+tPA group was significantly smaller than in the tPA group 
(see Figure 3.4). 
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Plotting CBF lesion volume versus clot length gives the clot lysis profile for each animal 
over time. In the vehicle group no clot lysis was observed as indicated by consistent CBF 
lesion volumes and clot lengths over time (Figure 3.5A-E). Following thrombolysis all 
animals demonstrated a reduction in CBF lesion volumes and clot lengths with rA2+tPA 
animals displaying the most complete clot lysis and reperfusion.  
Figure 3.4 Temporal evolution of A) T1-weighted imaging derived clot length and B) perfusion lesion 
volume in the experimental groups. *Significant difference between treatment group and control. 
#Significant difference between treatment groups. p < 0.05. Note, n = 5 for the last imaging time-point in 
Figure B for the rA2+tPA group. 
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Figure 3.5(A-E) Scatter plot graphically displaying the time course of clot lysis and perfusion 
restoration in vehicle, tPA and rA2+tPA treated. Both treatment groups show migration toward 
restoration of perfusion deficit and clot lysis. All animals in the rA2+tPA group had complete clot lysis 
while only half of the tPA animals had complete clot lysis. 
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There was a non-significant reduction in the ADC lesion volumes between the 
two treatment groups and the vehicle groups at 150 minutes post ES (Figure 3.6). 
MRAs revealed a significant effect of treatment on vessel patency (p<.05) but no 
difference between the three treatments. The results are displayed in Table 3.2. 
 
 
 
 
 
 
 
 
 Treatment 
 Saline tPA tPA+rA2 
Pre treatment 2.80±.5 3±0 3±0 
Post treatment 2.60±.5 1.5±.93 1.63±.74 
Table 3.2 MRA vessel patency data from the treatment groups prior to and following treatment. 
3=complete occlusion, 2=partial occlusion, 1=no occlusion.   
  
Figure 3.6 Temporal evolution of the ADC-derived ischemic 
lesion volumes. Values presented as % of the 30 minutes 
lesion. 
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3.7 Discussion 
This study describes a novel approach for MR visualization of clot and clot lysis in a 
rat embolic stroke model by adding Magnevist©, a widely available MR contrast agent, to 
the blood prior to clotting. 
The utility of this approach is to compare directly the efficacy of thrombolytic 
agents on speed and completeness of clot lysis. Prior studies indirectly assessed 
thrombolytic efficacy by comparing DWI/PWI derived lesion volumes, MRA or final 
infarct volume on histology (37,107,115). However, directly visualizing clot integrity is 
especially important at late therapeutic time points in which the ‗no or low reflow 
phenomenon‘ may occur (116). Complete recanalization can potentially occur with a 
small or non-existent response of the CBF or DWI lesion volume. Information about clot 
lysis enhances the overall understanding of the results of treatment and more completely 
answers questions about the mechanisms of success or failure of an investigational stroke 
treatment. Further, this methodology allows for more complete characterization of the 
emoblic stroke model. Our results show that a wide variety of clot configurations occur in 
the cerebral vasculature which may explain some of the variability seen in this model 
(36).  
Clot length was used to determine clot lysis in vivo. This metric directly defines 
the temporal efficacy of different thrombolytic agents independent of surrogate markers 
such as perfusion deficit or TOF-derived blood flow. Together with perfusion and 
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diffusion imaging, imaging of clot lysis allows for a more thorough characterization of 
the efficacy of thrombolytics in an ES model. 
To show the utility of this method, we compared the effects of vehicle, tPA alone, 
and rA2+tPA treatment. rA2+tPA more reliably produced thrombolysis relative to tPA 
alone. Our results show that half of all tPA animals had some clot remaining in the 
arteries while no animals in the rA2+tPA group had clot remaining. At the final imaging 
time point following treatment, rA2+tPA resulted in statistical smaller perfusion lesion 
volume in the rA2+tPA group then the tPA group. Further, rA2+tPA resulted in an earlier 
statistically significant difference in CBF deficit volume versus vehicle compared to tPA 
alone.  
rA2 is thought to operate as a cell-surface receptor for both plasminogen (the 
inactive precursor of plasmin), and its activator, tPA (117,118). The rA2-tPA-
plasminogen triple complex is more effective than tPA alone in converting plasminogen 
into plasmin (119,120). Our previous study confirmed the enhanced plasmin generation 
by rA2+tPA in vitro and demonstrated rA2+tPA improved neurological outcomes in a rat 
focal embolic stroke model (105). It is possible that rA2+tPA generates more plasmin at 
the clot site because it has been demonstrated that the plasmin precursor, plasminogen, 
binds to the endothelial cell surface and is enriched in the clot (120,121). Therefore, 
rA2+tPA may locally bind plasminogen and consequently amplify plasmin generation in 
the vicinity of the clot, resulting in more effective fibrinolysis. 
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Although we report faster and more complete clot lysis and reperfusion, there was 
no statistically significant difference in the final ADC lesion volume between groups. We 
hypothesize that this finding was due to the late initiation of treatment in this experiment. 
Previous findings in the rat suture model of stroke showed that after 95 minutes of 
ischemia, recovery of the ADC lesion was non-significant (89). Future experiments 
should investigate the relationship between lysis efficacy and ADC lesion resolution. 
The clot imaging protocol was limited as it is only sensitive to clot localized in 
the bifurcation of the ICA, ACA, and MCA. Sections of the MCA distal to the M1-
segment were not visible. At the current resolution, larger imaging field of views would 
require lengthier scans and therefore would impede the ability to do other scans and limit 
the temporal scanning during the acute stroke phase and at multiple time points during 
treatment. 
To summarize, in this study we: (1) successfully developed a methodology that 
enables us to visualize clots using a contrast reagent Magnevist© in a focal rat embolic 
stroke model; (2) used this new method to characterize clot lysis dynamics during 
thrombolytic therapy; and (3) documented that tPA+rA2 yields faster and more consistent 
thrombolysis than tPA alone. This new methodology provides a novel approach to 
preclinically evaluate investigational thrombolytic agents. 
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 Chapter IV: Evaluation of Oxygen Sensitivity of Hyperpolarized 
Helium Imaging in the Detection of Pulmonary Ischemia 
Ronn P. Walvick, Austin L. Reno, Matthew J. Gounis, Mitchell S. Albert 
From the Department of Radiology, University of Massachusetts Medical School, 
Worcester, MA 01604 
4.1  Preface 
The longitudinal relaxation of hyperpolarized helium is highly dependent on the 
oxygen content in the gas. This sensitivity has been exploited to measure the initial 
partial pressure of oxygen in the pulmonary air spaces and the oxygen transfer from the 
airspaces to the lung which both indirectly measures pulmonary blood perfusion. In this 
work, we evaluate the sensitivity of this measurement to pulmonary ischemia in rats 
using both simulation and an experimental model of pulmonary embolism. The average 
initial partial pressure of oxygen and oxygen depletion rate were elucidated in a cohort of 
normal to determine proper parameters for simulation of ischemia. A rat model of 
pulmonary ischemia was utilized to examine the sensitivity of these measurements to 
disease. My contributions to this work include running simulations, animal handling, 
experimental design, collecting and analyzing MR data, and principle authorship of the 
manuscript. 
4.2 Acknowledgements and Funding 
We acknowledge the technical assistance of Joey Mansour and Jaime Kinnear.  
Further, we acknowledge Dr. Michael A. King for assistance with simulation, and Dr. 
John Roche for thoroughly reviewing and editing the manuscript.  
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4.3 Introduction 
About six-hundred thousand new incidents of pulmonary embolism following deep 
vein thrombosis are reported per year in the U.S. (63). Given the high incidence of this 
condition, advances in diagnosing and assessing treatment for pulmonary embolism are 
crucial. Small mammal models of pulmonary ischemia have been found to be useful in 
evaluating the pathophysiological response to pulmonary embolism, and the effect of 
treatment on the restoration of normal lung function (65,122,123). Imaging of this 
process in small mammals is made difficult by physiological factors such as high heart 
and respiratory rate, and by technical limitations imposed by the necessity of high spatial 
and temporal resolution. Pulmonary MRI using hyperpolarized gas has emerged as a 
technique to circumvent many issues inherent to pulmonary imaging (12,79). By 
mapping the signal decay of hyperpolarized helium-3 (HP-He) during an extended breath 
hold, we can obtain information about the initial partial pressure of oxygen (po) and the 
oxygen depletion (16,124). Both parameters yield information about the efficiency of 
oxygen transfer from the airspaces to the blood, which is related to the local pulmonary 
blood perfusion. 
Whereas this measure has been shown to be a sensitive and reproducible measure 
of pulmonary ischemia in large animal models of pulmonary embolism, no one has yet 
elucidated information about the sensitivity of this measure to disease in rodents 
(83,125). Cieślar et al. described the first measurements of the po and oxygen depletion 
rate in rats and mice, but did not measure these parameters in animals with simulated 
ischemia (16,84). Validating this method in small mammal models of simulated ischemia 
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will allow for its use in understanding pulmonary ischemia pathophysiology and 
treatment efficacy. 
In this work, we characterize the effects of ischemia on the exchange of oxygen 
between the airspaces and the blood in an experimental model of rodent pulmonary 
embolism. As performed in previous studies, we used a single acquisition method to map 
both of the aforementioned parameters, as well as to account for local flip angle 
variations (16). We used the data to simulate varying levels of ischemia, and to ascertain 
the sensitivity of the HP-He-derived alveolar oxygen measurement method in small 
animals. We hypothesize that 1.) the measurement of the longitudinal relaxation time of 
hyperpolarized helium is sensitive to pulmonary embolism and 2.) moderate to high SNR 
images are necessary to detect changes in pulmonary ischemia by the measurement of the 
longitudinal relaxation time of hyperpolarized helium. 
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4.4 Methods 
4.4.1 Animal Handling 
Animal procedures were approved by the University of Massachusetts 
Institutional Animal Care and Use Committee. Twelve Sprauge Dawley rats were 
anesthetized with 5% isoflurane and maintained at 1.5–2.0% isoflurane in oxygen. 
Animals were separated into either a control group (n = 6) or an experimental group (n = 
6). All animals received tracheotomies. No further interventions were conducted on 
control animals. Experimental animals were transported to an angiosurgical suite (Philips 
Allura FD20; Best, the Netherlands) that was adjacent to the MRI suite. Under 
fluoroscopic guidance, a microcatheter was advanced over the wire via a transjugular 
approach to the selected pulmonary branch. Correct positioning was confirmed with 
digitally subtracted angiography. After flushing the microcatheter with 5% dextrose 
solution, the branch was embolized with a 3:1 mixture of n-butyl-2-cyanoacrylate and 
Lipiodol, respectively (Codman Neurovascular, Raynham, MA). Once the pulmonary 
artery branch was embolized, we transferred the animals to a 3.0T Philips Acheiva 
Clinical MR scanner for imaging. Animals were connected to an anesthesia circuit that 
allowed for spontaneous respiration with the capability of administration of HP-He. 
Animals were continuously warmed with a hot air small animal heating system. We 
conducted physiological monitoring using an MR-compatible small animal monitoring 
device (SAI, Stonybrook, NY).  
 
96 
4.4.2 MRI Methods 
MR imaging was conducted using a single-turn solenoid coil tunable to both the 
proton and helium frequencies. Proton localizer scans were conducted to ensure proper 
positioning of the animal. Twelve hours prior to imaging, helium was polarized to 10–
20% on a custom-made helium polarizer. A volume of 6 ml of HP-He and 2 ml of oxygen 
were withdrawn and mixed in a syringe just prior to administration to the animal. The 
amount of oxygen was chosen based on the work by Ciéslar et al. in rats to optimize the 
tradeoff between SNR of the images and ascertain meaningful oxygen uptake rates (16). 
Once administered, a 24-second breath hold was imposed on the animal, during which we 
conducted helium imaging. The helium sequence was similar to that of Fisher et al., and 
consisted of two consecutive images acquired with no delay for radio-frequency power 
calibration, followed by an image every 2 seconds (125). Details of the imaging sequence 
were as follows: FOV = 50 mm, Recovery Time=4 ms, Echo Time=980 μs, Flip Angle = 
~10°, MTX = 64x32, and slice thickness = ∞ (i.e., projection image). After acquisition, 
the images were zero-filled to achieve a final matrix size of 64x64.  
4.4.3 Analysis of Initial Partial Pressure of Oxygen and Oxygen Depletion Rate 
Analysis of initial pO2 and oxygen depletion rate has been described in depth in 
other works (16,125,126). The decay rate of HP-He in the presence of oxygen      ) can 
be described as (16,127): 
           
                                                    [4.1] 
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where pO2 is the partial pressure of oxygen, apnd ξ is a constant equal to 2.6 bar·sec. 
Assuming correction for RF depolarization, the time course of the signal decay can be 
described by (16): 
      
       
     
  
                                            [4.2] 
where Sm is the signal intensity at the m-th acquired image, So is the signal intensity of the 
first acquired image following the RF calibration in the sequence, and η is the delay 
between image acquisitions. Assuming a linear uptake of pO2 in the lungs (16): 
                                                             [4.3] 
where po is the initial partial pressure of oxygen and R is the rate of oxygen uptake into 
the blood. Substituting equation [3] into equation 2, equation 2 can be expressed as (16) 
 
     
  
  
  
  
                                                    [4.4] 
where t = mη/2. This equation can be solved by performing a linear fit using a least 
squares method. 
The effect of RF depolarization was quantified by (17): 
            
  Δ   
                                                 [4.5] 
where      and     is the first and second RF calibration image, respectively acquired, 
and ΔηRF is the time between the acquisition of the center of k-space of images S-1 and So. 
The flip angle can be calculated from ε by (125) 
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                                                    [4.6] 
where N is the number of phase encodes and α is the flip angle. 
Each image was divided by ε to eliminate the influence of RF depolarization on 
the measurement of po and R. Because the measurement of po affects the calculation of ε, 
which in turn affects po, we iteratively determined the values of R, and ε until 
convergence was reached. 
4.4.4 Image Analysis 
In control animals, two region of interests (ROIs) were placed in both the left and 
right lobe of the lung for quantitative measurement of po and R. In experimental animals, 
ROIs were selected in areas of ischemia as indicated by digital subtraction angiography, 
as well as in the contralateral side, and analyzed for po and R. Assuming a Gaussian noise 
distribution, we measured the SNR of these ROIs through the division of the signal 
intensity by the standard deviation of the noise. 
4.4.5 Simulation 
To characterize the accuracy and precision of the measurement at various SNRs, 
the noiseless time course of the decay of the HP-He signal is expressed as (125)  
            
   
 
 
 
      
 
 
       
                                  [4.7] 
where Mx is the simulated value of the time course of helium decay at acquired image x 
and M1 is defined by (125)  
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  Δ   
                                             [4.8] 
For purposes of simulation, Mo was set to 1. We used average values for po, R, and α of 
the contralateral lung in the experimental animals as starting points for simulation. To 
simulate the in vivo ROI analysis, we generated 25 noiseless curves. We varied the SNR 
of the curves between 12–200 through the addition of Gaussian noise by: 
      
 
   
                                                     [4.9] 
where Am is the simulated signal intensity at time t during the acquisition, Mm is the noise 
free data acquisition value derived from equations 4.7 and 4.8,, and n is a random number 
generated from a Gaussian distribution with μ=0 and ζ=1. We averaged the noise 
modified curves together and conducted the identical in vivo analysis. Next, to simulate 
the embolism condition, we raised and lowered values of po and R, respectively, by 90% 
in increments of 15% of the original. We also determined the accuracy and precision of 
the measured parameters. The simulation was performed 1000 times and the average and 
standard deviation of the fitted values of po and R were determined at each SNR. We 
considered a particular value of po or R at each level of ischemia differentiable from 
another level of ischemia if the measured values were two standard deviations of the 
mean away from each other.  
4.4.6 Statistics 
All statistical analyses were conducted on SPSS Statistics software (SPSS, 
Chicago, IL). Comparisons of quantitative values of po, R, and flip angle in control and 
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experimental animals were conducted using a one-way ANOVA with a post-hoc 
Bonferroni multiple comparison test. Data are expressed as mean ± 1 STD.  
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Results 
Figure 4.1 shows representative images of the results of the surgical procedure on 
the experimental rats. Figure 4.1a illustrates the placement of the embolic material in the 
pulmonary artery visualized by radiography. Figure 4.1b was obtained during the peak 
opacification, showing hypoperfusion in the embolized lung. The model produced focal 
ischemia in the anterior and middle portions of the left lung. Due to anatomical overlap of 
the inferior portion of the left and right lungs, it was not possible to determine the extent 
of ischemia in this area. 
  
Figure 4.1 Radiographs visualizing the results of the pulmonary embolic surgery. A.) A 
radiograph of an experimental animal post pulmonary embolism placement.  The dashed arrow 
points to the embolic material situated in a division of the left pulmonary artery. The material is 
radio-opaque of the artery. B.) Visualization of the opacification of the lung during iodinated 
contrast bolus transit. The solid arrows indicate areas of low perfusion as determined by minimal 
opacification.   
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Figure 4.2a-f displays two sets of HP-He images in animals with and without 
ischemia at 0 seconds, 10 seconds, and 24 seconds following helium administration, 
respectively. The partial pressure of oxygen, po, the oxygen depletion rate, R, and flip 
angle, α, were determined from an ROI analysis from the center of each lung. Figure 4.3 
displays the time course of PO2 in ROIs localized in the ischemic and contralateral lungs 
in the animals displayed in Figure 4.2.  
 
 
Figure 4.2 Representative images of the decay of the hyperpolarized helium signal in the lungs in normal 
(A-C) and embolized (D-F) animals 0 (A,D), 10 (B,E) and 24 (C,F) seconds after helium administration. 
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Results in control animals reveal values for po, R, and α in the left lung of 162.13 
± 33.28 mbar, 6.40 ± 1.05 mbar/s, and 5.41 ± 1.19°, respectively, in the left lung, and 
167.55 ± 43.35 mbar, 6.35 ± 1.00 mbar/s, and 5.25 ± 1.04°, respectively, in the right 
lung. In the experimental animals, the values of po, R, and α in the ischemic lung were 
244.85 ± 19.28 mbar, .017 ± 0.40 mbar/s, and 5.321 ± .50°, respectively. In the 
contralateral normal lung, results show values for po, R, and α of 149.10 ± 15.54 mbar, 
4.42 ± 1.07mbar/s, and 5.13 ± .74°. The statistical analysis revealed significant different 
values of po between the ischemic lung and the contralateral normal side, as well as 
between the ischemic lung and both sides of the control lungs. In the case of the oxygen 
depletion rate, R, there were statistically different values between the ischemic lung and 
the contralateral side. Further, we found significant differences between both control 
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Figure 4.3 The time course of the partial pressure of oxygen in an ROI in the ischemic 
and normal lobe of the animal displayed in Figure 2D-F. Note: t = mη/2 
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lungs and both experimental lungs, but no differences between the left and right control 
lungs. We found no statistically significant differences in measurement of α between any 
groups.  
We performed simulations to ascertain the ability of the measurement to detect 
varying amounts of ischemia based on the SNR of the initial imaging. Figure 4a and b 
plots the average and standard deviation for fits of po and R as a function of SNR at no 
ischemia (po = 149.10mbar, R=4.42mbar/s), 45% ischemia (po=216.19mbar, 
R=2.42mbar/s), and 90% ischemia (po=283.29mbar, R=0.44mbar/s). The minimum SNR 
required to separate po and R, respectively, at each level of ischemia from the normal 
case is summarized in Table 4.1 and 4.2. 
Figure 4.4 Simulated accuracy and precision of the measurement of A) po at 149.10 mbar, 216.19 mbar, and 
283.29 mbar and R at 4.42 mbar/s, 2.42 mbar/s, and 0.44 mbar/s.  Higher values of pO2 and lower values of R 
are characteristic of pulmonary ischemia.  Whereas both measures are accurate, po is considerably more 
precise then R.  The dashed line represents the actual simulated value of po and R. 
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 po (mbar) 
po (mbar) 149.10 171.46 193.83 216.19 238.56 260.92 283.29 
149.10 NA 125 65 43 32 26 23 
171.46 125 NA 127 64 43 33 27 
193.82 65 127 NA 128 64 44 33 
216.19 43 64 128 NA 124 64 44 
238.56 32 43 64 124 NA 126 66 
260.92 26 33 44 64 126 NA 128 
283.29 23 27 33 44 66 128 NA 
Table 4.1 Minimum SNR required to separate the values of po indicated by the row and column. NA: Not 
applicable 
 
 R (mbar/s) 
R (mbar/s) 4.42 3.74 3.08 2.42 1.76 1.1 0.44 
4.42 NA >200 196 134 104 87 75 
3.74 >200 NA >200 >200 142 110 90 
3.08 196 >200 NA >200 >200 147 117 
2.42 134 >200 >200 NA >200 >200 157 
1.76 104 142 >200 >200 NA >200 >200 
1.1 87 110 147 >200 >200 NA >200 
0.44 75 90 117 157 >200 >200 NA 
Table 4.2 Minimum SNR required to separate the values of R indicated by the row and column. NA: Not 
applicable. >200: SNR higher than 200 is required to separate the specified values of R. Simulation was not 
performed above SNR = 200. 
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4.5 Discussion 
In this study, we showed that pulmonary ischemia in rats is detectable using the 
oxygen sensitivity of HP-He through the monitoring of signal decay. Further, we showed 
that both the po and R show large changes in areas of ischemia versus the contralateral 
side. To our knowledge, this represents the first demonstration of the sensitivity of the 
HP-He alveolar oxygen measurement conducted in a small animal model of permanent 
pulmonary ischemia. 
Our model results in severe pulmonary ischemia that encompasses a majority of 
the occluded lung, as evidenced by the angiographic data. As compared to the 
contralateral lung, this occlusion results in both significantly elevated po and a reduced 
rate of oxygen uptake in the ischemic lung. These results further confirm the findings in 
other studies performed in large animal models of pulmonary ischemia. In previous small 
mammal models of pulmonary ischemia, investigators injected varying sized beads or 
homogenized clots into the venous system of rats (65,122,128). This produced a 
permanent and diffuse pulmonary ischemia. Crémillieux et al. infused air into rats in the 
decubitus position, which resulted in a one-sided, whole-lung pulmonary embolism (79). 
The ischemia dissipated over time, resulting in a transient insult. Our model is both focal 
and permanent, allowing for the study of stable ischemia.  
One contradictory finding of our study is that the oxygen depletion rate in the 
contralateral side in experimental animals was significantly lower than that of both sides 
of the control animals. A possible explanation for this is that the process of catheterizing 
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the pulmonary artery affects cardiac function. Further, the catheterization of the superior 
vena cava reduced the preload on the heart which may reduce the cardiac output. Indeed, 
we observed a reduction in the heart rate following surgery. Indeed, Möller et al. showed 
a relationship between po and R to cardiac output (15). Nevertheless, the difference of 
both R and po between the ipsilateral and contralateral sides in experimental animals was 
significantly larger than those between the two sides of the control animals. 
The simulation results revealed the importance of the SNR of the images in 
differentiating between normal and ischemic tissue in cases of mild and moderate 
ischemia. Simulation revealed both high accuracy and high precision of the experimental 
measurements of po at experimentally relevant SNR at all levels of ischemia. This was in 
contrast to the measurement of R, where a reduction in the oxygen uptake due to 
ischemia resulted in a decrease in measurement precision. The accuracy of the 
measurement of R, however, was quite robust at experimentally relevant SNR values. 
According to our simulations, the SNR of the images obtained would allow for 
robust detection of changes in po and R, of at least 15% and 60% of normal, respectively. 
Mild, moderate, and severe ischemia can be differentiated from normal function on the 
basis of po, whereas R can only differentiate between normal function and severe 
ischemia. The results suggest that po may be a more reliable parameter to use when 
attempting to differentiate between the severities of ischemia.  
In order to improve the usefulness of R as a sensitive parameter of ischemia, an 
improvement of SNR of the images must be achieved. Higher SNR can be realized by 
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increasing the gas polarization, lowering the acquisition matrix, or increasing the flip 
angle. Increasing the flip angle of the imaging sequence will result in higher signal 
intensity, but may limit the number of useable images in the time course of the HP-He 
decay. This approach can be combined with a non-Cartesian k-space acquisition 
technique, such as spiral k-space mapping to lower the effect of using higher flip angles 
by sparsely sampling k-space (16). 
The usefulness of this method in characterizing pulmonary embolism is two-fold. 
First, the measurements reflect the true physiology of the lung—the transfer of oxygen 
from the air spaces to the blood supply. Although many methods exist to measure blood 
perfusion to pulmonary tissue, few can assess the overall condition of lung function. 
Second, because this method uses no injected contrast agents, it is repeatable over the 
time course of the disease and following treatment. This feature will allow for 
comparative testing of pharmaceutical intervention on the ability to restore perfusion and 
normal pulmonary function following ischemia. 
Other measures have been proposed to evaluate pulmonary ischemia using proton 
and non-proton methodology in rats. Mistry et al. suggested using multiple injections of 
contrast agent timed to the respiratory and cardiac cycle to obtain a bolus-contrast time 
curve in the lungs (81). Similarly, Dimitrov et al. suggested observing the de-phasing of 
the helium signal following injection of contrast agent (85). Both methods allow for 
mapping of the pulmonary blood flow in the lungs. Whereas it is sensitive to ischemia, 
the former method requires a technically challenging setup to inject contrast agent. 
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Further, both measures only look at blood flow to the tissue. The oxygen sensitivity 
measurement quantifies the actual physiology of the lung tissue (i.e., the transfer of 
oxygen from the airspace to the lung). To see the effect of restoration of blood flow on 
pulmonary function, it may be advantageous to measure blood perfusion using a contrast 
or arterial spin-labeling technique, and to measure pulmonary function using the oxygen 
sensitivity measurement in treated tissue. Pulmonary reperfusion is typically 
accompanied in edema, which may not allow the lungs to return to full function even 
though perfusion has been restored (129). 
This study had limitations. Whereas our animal model of ischemia caused 
localized deficits, the deficits were large. Further, the ischemia was produced through the 
injection of non-biologic material. The model should be refined to use thrombi to cause 
ischemia that is treatable by thrombolytic compounds. From an imaging prospective, 
whole volume (projection) imaging was performed on the lung to measure the signal 
decay to ameliorate the diffusional motion of helium on the measurement. Future 
research should look at three-dimensional helium acquisitions to more finely localize the 
ischemic area, as suggested by Gast et al. (87). Finally, the quantitative values of po may 
be underestimated. As mentioned in the Crémillieux et al., a delay in the time between 
complete administration of the helium may result in the underestimation of po due to 
uptake of oxygen during this time (79). In the current study, the duration between the 
beginning of the breath-hold period and the start of the scan was between 4 and 5 
seconds; this may have resulted in an underestimation of the po between 25.60 to 32.00 
mbar.  
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In conclusion, our results demonstrate that the po and R, as measured by the T1 
decay of HP-He, is sensitive to pulmonary ischemia in rats. This finding can be useful in 
understanding the effects of pulmonary ischemia on lung function in rodents, and may 
eventually be used to ascertain the effect of treatment on the recovery of lung function.  
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5.1 Preface 
Tissue blood volume can be determined from the change in T1-weighted Magnetic 
Resonance (MR) signal intensity due to the injection of a strictly intravascular contrast 
agent. This study was designed to elucidate the optimal imaging parameters for 
measurement of pulmonary blood volume (PBV) in rats using simulations and utilize 
these parameters to measure the change in PBV during hypoxia, a well known pulmonary 
vasoconstriction stimuli. My contributions to this work include running simulations, 
animal handling, experimental design, collecting and analyzing MR data, and principle 
authorship of the manuscript. 
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5.2 Abstract 
Objective: The purpose of this study was to develop a novel magnetic resonance imaging 
(MRI) based technique for the measurement of pulmonary blood volume. The method 
was evaluated via simulation and validated through animal experiments utilizing a model 
of pulmonary hypoxic vasoconstriction. 
Methods: The proposed method consisted of acquiring images of lung parenchyma with 
an inversion recovery, T1 weighted spin-echo sequence before and after the injection of a 
long half-life, intravascular contrast agent. Simulation was performed to characterize the 
accuracy and precision of this methodology. Images of lung parenchyma were acquired 
in Sprague Dawley rats subjected to either inspiration oxygen level of 60% or 14%.  
 Results: Simulation revealed good accuracy and precision of the measurement at 
relevant signal to noise ratios. Better accuracy was obtained with shorter inversion times 
while the precision of the measurement was increased with higher inversion times. The 
results from the animal experiments revealed a significant decrease in the measured 
pulmonary blood volume in animals breathing gas with lower oxygen content. The 
measured PBV increased with increasing inversion time, in line with simulations. 
Conclusion: The results presented here showed the utility of this methodology for 
measuring the pulmonary blood volume imaging in animal models of hypoxic pulmonary 
vasoconstriction. The measurement of pulmonary blood volume using MRI may have a 
role in both experimental and clinical imaging of pulmonary vascular function. 
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5.3 Introduction 
Microcapillary pulmonary blood volume (PBV) is a sensitive measurement of 
pulmonary vascular physiology (130-132). Pulmonary blood volume constriction is 
thought to be a natural response to alveolar hypoxia (57). Further, PBV is regionally 
reduced due to ischemia as a result of pulmonary embolism (133).  
Measurement of PBV can be performed in a number of ways. PBV can be 
measured by ascertaining the diffusing capacity of carbon monoxide (DLCO) using 
spirometry (48). Following inhalation and breath hold of CO, the concentration of CO in 
the expiratory gas can be measured and compared to the inhaled concentration. The 
uptake of carbon monoxide is related to the PBV. This measurement offers only a global 
measurement of the pulmonary blood volume (48).  
Spatially localized techniques utilizing imaging allows for a regional determination 
of PBV. Nuclear Medicine techniques such as single photon computed tomography 
(SPECT) has the ability to measure the distribution of an intravascular radiotracer, 
technetium-99m macroaggregates of albumin ([99mTc]MAA) through the pulmonary 
vasculature (77). The distribution of the radiotracer in the lungs is related to the PBV. 
While nuclear medicine based exams offer spatially localized measurements of 
pulmonary blood volume, magnetic resonance imaging (MRI) may have the ability to 
measure PBV without the use of ionizing radiation. Steady state techniques, analogous to 
SPECT determination of blood volume, measure changes in the MRI relaxation 
properties of tissue before and after injection of an intravascular contrast agent. In one set 
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of techniques, a gadolinium based contrast agent is used in conjunction with aT1 
weighted inversion recovery or spoiled gradient echo sequence. These techniques have 
been used to measure many disease processes such as cancer and stroke (134-136). 
The purpose of this study is to adapt the MRI based T1 weighted steady state blood 
volume technique for the measurement of PBV. The typical implementation of these 
techniques, however, is not suited for measurement of pulmonary blood volume. These 
sequences are gradient echo based which results in low signal from the lung parenchyma 
due to the extremely short T2* relaxation (134,135). Further, because of respiratory and 
cardiac motion, a physiological gating scheme must be implemented. 
We propose the use of a T1 weighted, inversion recovery prepared sequence with 
spin echo acquisition imaging to optimize the signal from the lung parenchyma. Although 
the lung parenchyma has a short T2*, the T2 of the lungs is on the order of 60-80ms, 
making spin echo sequences appropriate for lung imaging (137). Further we describe a 
gating scheme which will allow for maintenance of the steady state magnetization for 
accurate blood volume measurements. Simulation will be conducted to explore the 
tradeoff between inversion time and the effect of water exchange on measure of PBV. 
Also, the accuracy and precision of the exam will be determined as a function of 
physiological and imaging parameters. The measurement of PBV will be applied to 
measure the PBV in Sprauge Dawley rats breathing either 60% or 14% O2 to explore the 
ability of our method to measure PBV and its changes during HPV. We hypothesize that 
1.) the accuracy and precision of the PBV is dependent on inversion time and exchange 
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rate, 2.) the proposed MRI PBV measurement is sensitive to hypoxia, and 3.) the SNR of 
the lung parenchyma is adequate for the measurement of PBV.  
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5.4 Materials and Methods  
5.5 Theory 
Donahue et al. introduced the use of an inversion recovery prepared T1 weighted 
pulse sequence for the measurement of capillary blood volume (138). In this technique, 
the authors utilized the Hazelwood model which relates the MRI signal intensity from the 
tissue, Stissue, to inversion time, TI, the blood longitudinal relaxation time, T1v, the 
extravascular relaxation time, T1ev,  water exchange rates between the intravascular and 
extravascular space (
 
  
 
 
   
 , the fractional intravascular and extravascular volume (fv,fev) 
and longitudinal magnetization, Mo as (138,139): 
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In these equations, only the exchange affected parameters are measurable (T1ev´, T1v´, 
fev´, fv‘). With estimates of the exchange rates,  
 
  
 
 
   
 , one can obtain values for the 
exchange independent intra and extravascular longitudinal relaxation times and volume 
fractions. The terms intravascular volume and pulmonary blood volume are 
interchangeable in this report. 
 To simplify the calculation of vascular volume, assumptions can be made about 
the exchange rates. Donahue et al. has shown that using a model where
 
  
 
 
   
  , the 
fractional blood volume can be determined by (138) 
   
                      
                    
                                                 [5.2] 
where Stissue,pre and Stissue, post is the signal intensity in the lung parenchyma before and 
after contrast injection and Sblood,pre and Sblood, post is the signal intensity from the blood 
before and after contrast injection. 
This ‗no exchange model‘ has been shown to produce accurate measurements of 
fractional blood volume even in domains of high exchange. The alternative ‗fast 
exchange model‘ assumes
 
  
 
 
   
  . The calculation of fv in this model requires the 
measurement of the longitudinal relaxation time prior to and following injection of a 
contrast agent (138). Accelerated methods of mapping the longitudinal relaxation time 
exist but usually require the utilization of a gradient echo readout which is difficult to 
implement in the lungs. Therefore, we will utilize the ‗no-exchange‘ model in our 
measurement of PBV. 
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5.5.1 Simulation 
Simulation will be used to determine the effect of inversion time, water exchange 
rate and SNR of the images on the accuracy and precision of the blood volume 
measurement. The pre and post contrast injection signal intensity will be simulated by 
calculating equation 5.1 using assumed values of T1 for the intravascular space before 
and after contrast injection. The signal from blood will be calculated as 
             
   
                                               [5.3] 
Table 1 lists the various parameters for simulation. 
The addition of noise will be simulated by varying the signal intensity of the pre 
and post contrast by 
                     
 
   
                                             [5.4] 
 where n is a random number generated from a 
Gaussian distribution with μ=0 and ζ=1. 
Equation 5.3 assumes the magnetization (Mo) is 
equal to 1. For purposes of simulation, the SNR 
refers to the achievable SNR if the inversion 
time approached 0 seconds. The fractional blood 
volume will be calculated by equation 5.1 using 
the noise adjusted signal intensities. For each set 
of inversion times and exchange rates, the simulation was performed 1000 times and the 
average and standard deviation of the simulated values were reported. 
Parameter Value 
Precontrast Blood T1 (T1v)  1.664s 
Post Contrast Blood T1  0.215s 
Extravascular Tissue T1 0.874s 
Fractional Blood 
Volume(fv) 
.3 
Extravascular Blood 
volume(1-fv) 
.7 
Inversion Time(TI) .1-.6s 
Exchange Rate (1/η) 1-30Hz 
Initial Magnetization (Mo) 1 
Lung Parenchyma SNR 20-200 
Table 5.1Parameters used for blood volume 
imaging simulation 
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5.5.2 Animal Experiments 
Animal procedures were approved by the University of Massachusetts 
Institutional Animal Care and Use Committee. 10 Sprague Dawley rats were injected 
subcutaneously with 5uL/g B.W. of a mixture of 100mg/ml Ketamine and 20mg/ml 
Xylazine. Once an acceptable plane of anesthesia was achieved, animals were fitted with 
a tail vein and subcutaneous catheter for administration of contrast agents and 
anesthetics, respectively. Following the initial anesthesia, animals were administered a 
maintenance dose of 1uL/g B.W. of the Ketamine and Xylazine mixture every 30-40 
minutes.  
Following catheter placement animals were transferred to a 3.0T Philips Acheiva 
Clinical MR scanner for imaging. Animals were connected to a closed anesthesia circuit 
that allowed for spontaneous respiration. Animals were continuously warmed with a hot 
air small animal heating system. Physiological monitoring was conducted using an MR-
compatible small animal monitoring device (SAI, Stonybrook, NY). Animals were 
exposed to breathing gas of either 60% O2 (n=5) or 14% O2 (n=5) during imaging.  
5.5.3 MRI Methods 
Animals were placed in the center of a Single Turn Solenoid RF coil tuned to the 
1H frequency. A solution of 20% Magnevist was placed next to the animal as a signal 
standard. Animals were positioned in the center of the magnet and positioning was 
confirmed with a localizing scan. For measurement of blood volume, an inversion 
recovery, spin echo sequence was used with the following parameters: TI = 100, 200, or 
300ms, TR = 6s, TE= 4.95ms, NSA =2, matrix Size = 128x64, slice thickness = 3mm, 
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and Field of View = 50mm. Images were interpolated to a matrix size of 128x128. In 
order to minimize physiological imaging artifacts, a simultaneous cardiac and respiratory 
gating scheme was implemented. To achieve image read out during mid cardiac cycle and 
end expiration, a trigger was administered to the scanner at a time equal to TI before 
image readout. The appropriate point to trigger the scanner was predicted by the recent 
historical heart rate and respiratory rate of the animal. Figure 1 graphically describes this 
process.  
Images were recorded with different inversion times prior to injection of an 
intravascular contrast agent, gadolinium-labeled protected graft copolymer (PGC-Gd). 
The agent has a measured half life in rodents of 14 hours with a relaxivity of 10-11 
(mm·s)-1 at a dose of 30umole Gd/kg. Following a five minute weighting period to allow 
for contrast agent circulation, the animal was reimaged with the identical imaging 
protocol. The effectiveness of the cardiac and respiratory gating scheme was evaluated by 
Figure 5.1Prospective gating scheme.  A trigger is received by the scanner from the small animal 
gating device TI miliseconds before the desired signal readout.  The readout occurred during the mid 
cardiac cycle and end expiration. 
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subtracting images acquired at the same inversion time. Misalignment of the heart and the 
pulmonary space were evaluated. 
5.5.4 Data Analysis  
Differences in physiological parameters (heart rate, respiration rate, and Oxygen 
Saturation (SPO2)) were evaluated using a one tailed Student‘s t-test with equal variance. 
Values of p<.05 were considered significant. 
Region of Interests (ROIs) were be selected in the ventral and dorsal area of each 
lung. Care was taken to avoid blood vessels and airways. An ROI were placed around the 
pulmonary artery vessel for measurement of Sblood,pre and Sblood,post. Finally, an ROI was 
placed around the phantom. The signal intensity of the ROIS from post contrast images 
was corrected for arbitrary changes in intensity via: 
                                         
Where Sphantom,post  and Sphantom,pre is the SNR before and after contrast injection. All 
values for signal intensity are adjusted for signal phase by comparing the sign of the 
intensity on images reconstructed to display real values on the post contrast images to 
that of pre contrast images  
 The corrected post and pre signal intensities will be used to calculate the PBV for 
each tissue ROI using equation 5.2. The blood volume measurements will be evaluated 
by a 3-way analysis of variance (ANOVA) to ascertain the effect of inversion time, 
anatomical position (ventral versus dorsal), and hypoxia on the PBV. A post-hoc 
Bonferroni multiple comparison analysis of the effect of inversion time on the PBV was 
conducted. Values of p<.05 was considered significant. Values of PBV are expressed as a 
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ratio between capillary PBV and pulmonary tissue volume (i.e., PBV + septal wall 
volume).  
The SNR of the pre-contrast image ROIs were calculated to determine the effects 
of hypoxia and inversion time on signal intensity. SNR was calculated by dividing the 
average signal intensity within the ROI by the standard deviation of the noise. The 
average values of SNR were evaluated with a 2-way ANOVA with hypoxia and inversion 
time as factors. A post-hoc Bonferroni multiple comparison analysis of the effect of 
inversion time on the SNR was conducted. Values of p<.05 was considered significant. 
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5.6 Results 
5.6.1 Simulation 
The simulated average and standard deviation of the measurement of PBV at short 
and long inversion time and an SNR level of 80 as a function of water exchange rate is 
given in Figure 5.2. The error in the 
measurement of PBV is increased as the 
inversion time is increased. Higher 
water exchange between the intra and 
extravascular space results in an 
increase in the error on the 
measurement of the PBV independent 
of inversion time. The error caused by 
exchange exhibits asymptotic behavior 
as higher exchange rates are realized. With increasing inversion time, the sensitivity of 
the measurement of PBV to exchange rate is increasingly severe. Although the 
measurement error increases with increasing inversion time, the precision of the 
measurement of PBV increases with increasing inversion time. Table 5.2 summarizes the 
results of the simulation. 
 
  
Figure 5.2 Results of simulation showing the accuracy 
and precision of the measurement of blood volume at 
inversion times of 100ms (circles) or 600ms(squares) as 
a function of exchange rate. 
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In animal experiments, we chose to interrogate inversion times equal to 100, 200, 
and 300ms to minimize the effects of exchange on the measurement error of PBV (see 
discussion section).  
5.6.2 Animal Experiments 
All animals tolerated anesthesia and hypoxia without adverse events. Animals 
breathing 14% and 60% inspired O2 exhibited a blood oxygen saturation of 64.00±5.29% 
and 97±3.464% and a heart rate of 330±43.48 beats per minute and 284.75±29.25 beats 
per minute respectively. The respiration rate for animals breathing 14% and 60% O2 
  
 Inversion Time 
Exchange 
Rate 
100ms 300ms 600ms 
0Hz .30±.03 .30±.02 .30±.01 
5Hz .30±.03 .32±.02 .35±.01 
10Hz .31±.04 .33±.02 .38±.02 
15Hz .31±.04 .34±.02 .38±.01 
20Hz .31±.04 .34±.02 .39±.02 
25Hz .31±.04 .35±.02 .39±.01 
30Hz .31±.03 .35±.02 .39±.01 
Table 5.2 Simulated pulmonary blood volume measurements as a function of inversion time and 
exchange. The actual simulated blood volume is .30. PBV is measured in units of ml of blood/ml 
of tissue. 
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Figure 5.4Images of rat lung parenchyma at TI=100(A, D), 200(B, E) and 300 (C, F) at pre 
(A-C) and post (D-F) contrast administration in a normal animal. 
Figure 5.3Subtraction image of images shown in 
Fig 5.5C and F.  Signal enhancement is clearly 
visible and no major misalignments of the images 
are visible. 
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83±4 and 73.75±21, respectively. A decrease in SPO2 (p <.05) with hypoxia while no 
difference in heart rate (p>.05) or respiration rate (p>.05) was observed. Figure 5.3 shows 
typical images of an animal breathing 60% O2 before and after contrast injection at 
different inversion times. Lung parenchyma was clearly visible in these images and 
motion artifacts were minimized. Figure 5.4 displays a typical subtraction of image from 
Figure 5.3C and 5.3F. No major misalignment of the images was observed.  
Analysis of the PBV revealed a statistically significant reduction of PBV with 
hypoxia (p <.05). The average PBV as a function of hypoxia and inversion time is given 
in table 5.3. The analysis revealed a significant effect of inversion time on the 
measurement of blood volume (p<.05).  
A post hoc analysis of the effect of inversion time on PBV reveals a significant 
increase in the PBV as inversion time is increased (TI=100ms vs. TI=200ms, p <.05, 
TI=200ms vs. TI=300ms, p<.05, TI=100ms vs. TI=300ms, p<.05). There was no 
significant interaction effect between hypoxia and inversion time. Analysis further 
revealed no statistical change in PBV between the ventral and dorsal PBV (p>.05).  
 Inversion Time 
Inspired 
O2 
100ms 200ms 300ms 
14% .08±.12 .16±.07 .27±.09 
60% .28±.08 .33±.085 .38±.0717 
Table 5.3 Effect of inversion time and inspired O2 on pulmonary blood volume. Data is 
expressed as ml of blood/ml of tissue. 
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The average SNR of the selected ROIs as a function of inversion time and 
inspired oxygen content is given in table 5.4. There was no effect of inspired oxygen 
concentration on the parenchymal SNR(p>.05), however, inversion time did have an 
effect on SNR (p<.05). A post-hoc analysis revealed that only the values of SNR from 
TI=100ms and TI =300ms are statistically significant; however, the data indicates a trend 
towards decreasing SNR with increasing inversion time. There was no interaction effect 
of inspired oxygen concentration and inversion time on the values of SNR. 
 Inversion Time 
Inspired O2 100ms 200ms 300ms 
14% 93.1876±19.54 80.93±18.79 69.52±10.05 
60% 96.25±28.48 86.13±32.08 73.67±32.08 
Table 5.4  Effect of inversion time and inspired O2 on precontrast SNR 
  
128 
5.7 Discussion 
In this report, we present results that show the feasibility of measuring 
microcapillary pulmonary blood volume using a T1 weighted, inversion recovery 
sequence using cardiac and respiratory gating. Our results show that PBV as indicated by 
our measurement is restricted as a response to alveolar hypoxia. We further demonstrate 
through simulation the importance of the selection of inversion time in the accurate and 
precise measurement of PBV.  
Our simulation results reveal the tradeoff between inversion time and the 
accuracy and precision of the PBV measurement. The accuracy of the measurement is 
reduced due to both exchange and increasing inversion time. Water exchange between 
the intravascular and extravascular compartment cause a ‗blurring‘ of the respective T1 
relaxation times resulting in a loss of accuracy of the measurement of PBV. It is therefore 
necessary for accurate measurements to use minimal inversion times. In counter balance 
to this, the precision of the measurement is reduced with shorter inversion times. At 
shorter inversion times, the absolute range of the signal change expected between pre and 
post contrast images is low at biologically relevant tissue blood volume ratios. It should 
also be noted that the improvement in precision is asymptotic as inversion time is 
increased.  
   The result of reduced PBV during alveolar hypoxia in the animal experiments 
confirms the results of other investigations of PBV during hypoxia using both invasive 
and non-invasive methods. Intravital fluorescence microscopy has been utilized to 
visualize vessel constriction during hypoxia. In one study, the authors measured the 
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response of diameter of medium and small diameter arterioles in mice. The diameter of 
these vessels reduced in response to hypoxia, although capillary diameter response was 
not measured (140). Further, in a model of regional airway obstruction, Mistry et al. 
observed a large decrease in the regional PBV corresponding to the airway obstruction 
(81). Other studies have indirectly observed HPV by observing changes in pulmonary 
artery pressure or pulmonary vascular resistance (141).  
In the animal experiments, we chose to investigate inversion times of 100, 200, 
and 300ms. Although the expected precision was low at these inversion times, selecting 
ROIs increased the number of voxels sampled and lowered the effect of measurement 
precision. Further, at SNR levels of the images were of sufficient level to produce an 
expected measurement standard deviation of between 5-15% as the inversion time 
increases from 100ms to 500ms according to the simulation.  
The results of values for PBV in the animals breathing 60% O2 slightly 
underestimate those reported in the literature. The average value for PBV in this group of 
rats measured at TI=100ms were used for a reference due to the minimal effect of 
exchange on the measurement. In a study by Burri et al., the ratio of capillary blood 
volume to septal volume (pulmonary tissue + capillaries) in mature rats was .357 
(measure derived by experimentally measured capillary volume of (.197±.030) divided 
by experimentally measured tissue volume of .551±.051) as measured by 
autoradiography versus .282 measured by the proposed method (142). In another study by 
Plopper et al. the ratio of pulmonary capillary volume to pulmonary tissue volume to .303 
(measure derived by experimentally measured capillary volume of (.087±.015) divided 
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by experimentally measured tissue volume of .287±.017) as determined by light 
microscopy techniques (143).  
The effect of water exchange on the measurement of PBV using the proposed 
technique may be particularly problematic due to the nature of pulmonary capillaries. To 
support efficient gas exchange, both capillary and alveolar walls are very thin. The thin 
capillary wall may reduce the barrier to water exchange between the intravascular 
compartment and the alveolar interstitial space. To our knowledge, direct measurements 
of non-osmotic water exchange between these compartments have not been directly 
performed. The experimental results obtained in this study suggest the exchange rate 
between the compartments may be high as indicated by the response of the measurement 
to increasing inversion time. As shown in simulation, increasing inversion times 
increases the observed measurement of PBV at higher levels of exchange. In this study, 
progressively higher inversion time resulted in large increases of PBV in both animal 
groups, although the magnitude of the increase was smaller in the group breathing 60% 
O2 then in the hypoxic group. This may reflect capillary wall modification during acute 
HPV. 
Pulmonary edema, a common co-occurrence with pulmonary disease, likely did 
not play a role in the reduced observed values of PBV in the hypoxic group. Pulmonary 
edema during alveolar hypoxia would result in an increase of the T1 in the extravascular 
compartment. Over the duration of the experiment, the severity of the edema may 
increase, resulting in a lower observed value of the PBV. Previous research in HPV 
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pathophysiology has shown that HPV does not result in pulmonary edema during the 
acute state (140).  
In this study, our imaging protocol had a total imaging time of 12.8 minutes per 
inversion time point. In order to improve the imaging speed, a centric reordered turbo 
spin echo sequence (cTSE) could be utilized for readout in place of the single echo 
acquisition. cTSE sequences have been successfully used for lung imaging in humans and 
in animals. Further, in this study, we acquired a single slice. A multislice approach is 
feasible; however, a number of considerations must be taken into account. First, each 
slice must be taken at the same point in the cardiac cycle. Previous studies have shown 
that pulmonary blood perfusion changes during the cycle (144). Secondly, Each slice 
must be recorded at the same inversion time for regional comparison of PBV. One 
solution may be a three dimensional acquisition which would take advantage of the cTSE 
readout to accelerate image acquisition.  
The proposed measurements of PBV may be useful in the study of a number of 
disease processes. Many pulmonary diseases result in vascular dysfunction. In severe 
cases of chronic pulmonary obstructive disease (COPD), patients experience pulmonary 
arterial hypertension (PAH) due to HPV (52-54). Invasive measurements of pulmonary 
artery pressure, commonplace in the monitoring of PAH, can be replaced with the 
proposed methods to evaluate the regional effect of treatment on the microcappilaries of 
the lungs. Further emphysema may be a promising disease to study with this protocol. 
Emphysema is characterized by a thinning of the alveolar wall (145). This would increase 
the fraction of the MR signal from the lungs associated with the intravascular space and 
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would be reflected as an increase in the PBV. Further, the destruction of the alveolar wall 
may result in an increase in the rate of water exchange between the vascular and 
extravascular spaces. Monitoring the PBV at progressively higher inversion times might 
yield information about this process. 
Although this method was tested in a rodent model of alveolar hypoxia, the 
method is easily translatable to clinical imaging protocols. While the contrast agent used 
in this study is restricted to preclinical imaging, the Food and Drug administration 
recently approved an intravascular contrast agent, gadofosveset trisodium (Ablavar©), for 
use in the clinic (146). Further, in combination with accelerated image acquisition use 
cTSE, breath hold imaging can potentially be conducted to completely ameliorate the 
effects of respiratory motion.  
In conclusion, we show the utility of proton based PBV measurements. The 
proposed methodology utilizes a cardiac and respiratory gated inversion recovery spin-
echo sequence to maximize the SNR from the lung parenchyma. We used an 
intravascular contrast agent to ascertain the PBV without the need for fast imaging 
necessary for DSC or DCE PBV measurement techniques. We have demonstrated this 
techniques sensitivity to HPV. Steady state MRI measurement of PBV may be useful for 
investigations of lung vascular physiology and disease.  
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 Chapter VI: Summary and Future Work 
This dissertation characterizes MRI techniques in the measurement of the effect 
of experimental models of disease on the neural and pulmonary vasculature of rodents.  
The work presented in this thesis creates a base for future research in detailing the 
physiological mechanisms of disease states and the effect of administration of 
experimental pharmaceutical treatments on the progression of disease.  The following 
chapter will summarize the main findings of the experiments described in this thesis and 
offer suggestions for future research directions. 
Chapter 3 of this dissertation provides a comparison of a continuous arterial spin 
labeling (CASL) perfusion imaging technique with a dynamic susceptibility contrast 
(DSC) perfusion technique in a rat model of experimental stroke.  Utilizing a 
combination of CASL derived cerebral blood flow mapping, apparent diffusion 
coefficient mapping, and histology, stroke subregions were segmented (core, penumbra, 
sustained reversal, and transient reversal).  Measurements of DSC derived relative 
cerebral blood flow (rCBF) were recorded in each of the stroke subregions over a number 
of time points following ischemia and reperfusion.  In animals with untreated stroke, the 
blood flow in the core and penumbra remained consistently low but constant.  Following 
reperfusion, blood flow increased to both the core and penumbral subregion.  Further 
areas designated as transient reversal had a higher although non-statically significant 
response to reperfusion then did areas of sustained reversal.  Finally, the results show that 
blood flow during ischemia is higher in areas of penumbra and sustained reversal.  Using 
the data obtained from the stroke subregions, a minimum threshold for rCBF derived 
134 
ischemia was derived.  This threshold was used to calculate ischemic tissue volumes 
which were comparable to those derived from CASL. 
The results presented in this work are useful to the preclinical stroke research 
community.  We showed the utility of DSC for the determination of ischemic lesion 
volume in experimental rat models of stroke. While CASL based methods are 
advantageous in many ways, the technical challenges of implementation are high and 
require specialized hardware.  DSC based perfusion methods are technically 
straightforward and require only an intravenous catheter; however, further validation was 
necessary to support the use of DSC perfusion measurements in experimental stroke.  The 
derivation of a threshold for DSC based determination of ischemia may allow for 
standardization of the measurements of the ischemic lesion in future experimental stroke 
research.   
Clinically, research using contrast enhanced perfusion measurements in both CT 
and DSC based MRI have been interpreted using the arterial input function corrected 
bolus time to maximum contrast concentration (tmax) (147).  In may be interesting to use a 
similar technique to map the response of tmax to stroke subregions both during acute 
stroke and subsequent reperfusion in an experimental model of stroke.  In combination 
with histology and diffusion weighted imaging, the physiological meaning of tmax can be 
more thoroughly explored.   
In chapter three of this dissertation, a method of labeling clots with a T1 contrast 
agent, Gd-DTPA, was demonstrated.  Clots were created with different concentrations of 
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contrast agent and the optimal concentration for signal enhancement was determined.  
Following optimization, clots were injected into the cerebral vasculature of rats to induce 
cerebral ischemia.  Clots were easily visualized in the area of the junction between the 
internal, anterior, and middle cerebral artery.  In untreated animals, in vivo measurements 
of clot length were consistent over time.  In animals treated with thrombolytic agents, clot 
length decreased over time.  These results were confirmed using histological visualization 
of the clot.  This method was used to compare the thrombolytic efficacy of recombinant 
tissue plasminogen activator (r-tPA) with a combination of r-tPA and recombinant 
annexin-2 (rA2).  Our results show that the combination of rA2 and r-tPA resulted in 
more efficacious clot lysis, although this did not lead to a statistically lower final volume 
of infarcted tissue.    
The presented method of clot visualization can be used in a number of ways for 
future experimentation.  One interesting area of study would be to explore the rate of clot 
lysis as it compares to the rate of reperfusion.  This would be helpful in further 
elucidating the physiological mechanisms of the ‗no-reflow‘ phenomenon where 
recanalization of large vessels can occur without complete microcapillary reperfusion 
(34,35).  Further, there has been a recent push to develop new thrombolytic compounds 
that ameliorate the risk of hemorrhage (148,149).  The clot imaging methodology 
presented may be useful in evaluating the efficacy of novel experimental thrombolytic 
agents.  In combination with other MRI parameters, the effect of these compounds on 
hemorrhage, infarct volume, and edema can also be determined. 
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 In the second part of this dissertation, results were presented on two different 
methodologies for measuring pulmonary vascular function. Chapter four of this 
dissertation shows the results of simulation and experimentation on the use of the oxygen 
sensitivity of hyperpolarized 3He (HP-He) to measure the efficacy of gas exchange 
between the lungs and the blood. We validated this method for use in monitoring the 
effect of ischemia on gas exchange in a rodent model of pulmonary embolism.  Our 
results show an increase in the initial partial pressure of oxygen and a decrease in the rate 
of oxygen uptake from the airspaces to the capillaries in areas of ischemia. Simulation 
reveals that the measurement of the initial partial pressure of oxygen is a more sensitive 
measure of ischemia then is the rate of oxygen uptake.  
 The proposed methodology can be used to characterize the restoration of gas 
exchange following the administration of thrombolytic compounds to recanalize the 
pulmonary artery.  As discussed in chapter one, an immune response accompanies 
reperfusion in an animal model of pulmonary embolism.  Characterizing the temporal 
response of the recovery of pulmonary gas exchange in relationship to the immune 
reaction following reperfusion may be translatable to the clinic by providing a clearer 
understanding the consequences of administration of thrombolytics in cases of severe 
pulmonary embolism. This methodology also should be extended to research involving 
other experimental models of pulmonary disease. The time course and effect of treatment 
on gas exchange in experimental models of diseases such as emphysema or acute 
respiratory distress syndrome may facilitate a clearer understanding and better treatments 
for pulmonary disease. 
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  In chapter five of this dissertation, we describe a novel methodology of measuring 
pulmonary blood volume (PBV) using proton based MRI with a cardiac and respiratory 
gated T1 weighted inversion recovery spin echo sequence following the injection of an 
intravascular contrast agent.  Results show that lung parenchyma in rats is visible using 
this methodology.  Further, the measurement of blood volume was consistent with reports 
from the literature.  Also, animals breathing a low concentration of oxygen have 
generalized reduced PBV, a result of hypoxic pulmonary vasoconstriction.  Simulation 
reveals that imaging parameters play a role in the accuracy and precision of the 
measurement of PBV. 
 As suggested in chapter fiver, future work should focus on improving the imaging 
acquisition time by implementing fast spin echo sequences.  Further, multislice 
acquisitions can be achieved using a three dimensional fast spin echo sequence.  Also, the 
exchange sensitivity of the measurement of PBV may be useful in characterizing the 
integrity of the pulmonary capillary and alveolar wall.  Kim et al. introduced a measure 
of vascular permeability, the water exchange index,  to characterize vessel integrity (134). 
The water exchange index is calculated as the ratio of the measurement of blood volume 
between exchange sensitive and insensitive imaging sequences. Using our proposed 
methodology, calculation of the water exchange index can be achieved for the 
measurement of pulmonary and capillary wall integrity. 
 In conclusion, this dissertation presents methodology to measure rodent neural 
and pulmonary vascular function during normal and diseased states. In the first part of 
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this dissertation, the use of DSC in the measurement of experimental cerebral ischemia 
was validated in a model of permanent and transient ischemic stroke.  Further, a method 
is described to visualize clot location and lysis in response to thromolytic compounds a 
rat model of embolic stroke.   In the second part of this dissertation, the use of the oxygen 
sensitivity of HP-He is validated in a rat model of pulmonary embolism and through 
simulation.  Finally, results are presented in the use of a novel lung imaging methodology 
for the measurement of pulmonary blood volume.  The methods presented in this 
dissertation will aid investigators in understanding the pathophysiology are response to 
treatment of neural and pulmonary disease. 
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Appendix I 
Physiological Data from Experiments Conducted in Chapter II  
 Permanent 
Model-Baseline 
Permanent 
Model- Four 
Hours Post 
Stroke 
Transient 
Model-Baseline 
Transient 
Model- Four 
Hours Post 
Stroke 
Mean Arterial 
Blood 
Pressure 
(mmHg) 
No Data (Blood 
Chemistry Only) 
108.33±11.25 No Data (Blood 
Chemistry Only) 
103.33±9.83 
pH 7.46±0.04 7.43±0.02 7.43±0.04 7.41±0.03 
pCO2 
(mmHg) 
36.50±5.02 37.14±2.00 42.24±6.13 40.23±7.86 
PO2 (mmHg) 61.22±6.26 73.86±9.25 66.50±10.10 62.67±12.58 
BE ecf 
 
2.25±3.06 0.00±2.45 2.90±1.85 0.83±2.40 
HCO3 
(mmol/L) 
26.33±2.98 24.70±2.11 27.37±2.07 24.30±4.88 
TCO2 
(mmol/L) 
27.22±2.86 25.71±2.14 28.80±2.25 26.17±5.27 
sO2 (%) 92.00±2.78 94.57±2.23 92.50±3.03 90.50±4.42 
Na (mmol/L) 135.75±2.87 136.17±1.17 137.30±2.11 142.17±5.12 
K (mmol/L) 4.48±0.30 4.27±0.22 4.05±0.37 3.97±0.75 
iCa (mmol/L) 1.30±0.08 1.31±0.02 1.31±0.07 1.22±0.13 
Glu (mg/dL) 201.00±24.07 179.00±14.86 208.90±71.19 176.83±60.66 
Hct 
(%Packed 
Cell Volume) 
38.63±2.62 40.50±1.52 38.40±2.88 35.67±3.78 
Hb (g/dL) 13.11±0.89 13.77±0.53 13.05±0.97 11.88±1.92 
pCO2:partial pressure of CO2, pO2: partial pressure of oxygen, BE ecf: base excess of the extra cellular 
fluid (mmol/L), HCO3:bicarbonate, TCO2: total carbon dioxide content, sO2: oxygen saturation, Na: 
sodium, K: potassium, iCa: ionized calcium, Glu: glucose, Hct: hematocrit,Hb: hemoglobin  
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Appendix II  
Physiological Data from Experiments Conducted in Chapter III Prior to Stroke 
 Saline tPA tPA+rA2 
Mean Arterial Blood 
Pressure (mmHg) 
No Data (Blood 
Chemistry Only) 
No Data (Blood 
Chemistry Only) 
No Data (Blood 
Chemistry Only) 
pH 7.43±.02 7.43±.03 7.42±.03 
pCO2 (mmHg) 46.06±3.03 44.66±4.64 45.70±4.10 
PO2 (mmHg) 64.33±7.66 69.20±7.40 66.0±7.54 
BE ecf 6.40±1.67 5.20±1.79 5.00±1.26 
HCO3 (mmol/L) 30.56±1.62 29.56±1.98 29.55±1.33 
TCO2 (mmol/L) 32.00±1.58 31.00±1.87 31.00±1.41 
sO2 (%) 91.80±3.42 93.60±2.30 92.50±2.51 
Na (mmol/L) 135.67±1.51 135.20±2.28 135.83±1.83 
K (mmol/L) 4.45±.39 4.72±.31 4.38±.31 
iCa (mmol/L) 1.35±.04 1.33±.03 1.34±.03 
Glu (mg/dL) 274.33±53.25 240.80±40.54 272.33±67.19 
Hct (%Packed Cell 
Volume) 
39.17±1.33 37.60±1.67 38.67±1.03 
Hb (g/dL) 13.30±0.45 12.80±.58 13.17±.36 
pCO2:partial pressure of CO2, pO2: partial pressure of oxygen, BE ecf: base excess of the extra cellular 
fluid (mmol/L), HCO3:bicarbonate, TCO2: total carbon dioxide content, sO2: oxygen saturation, Na: 
sodium, K: potassium, iCa: ionized calcium, Glu: glucose, Hct: hematocrit,Hb: hemoglobin  
  
157 
Physiological Data from Experiments Conducted in Chapter III Following Treatment 
 Saline tPA tPA+rA2 
Mean Arterial Blood 
Pressure (mmHg) 
101.11±4.082 100.00±7.07 98.333±4.08 
pH 7.33±.10 7.34±.05 7.32±.05 
pCO2 (mmHg) 53.45±12.15 52.96±6.43 51.12±7.50 
PO2 (mmHg) 48.83±6.59 42.20±9.01 56.67±14.08 
BE ecf 2.00±3.35 2.60±1.14 -0.17±1.16 
HCO3 (mmol/L) 27.83±2.37 28.44±1.04 25.87±1.06 
TCO2 (mmol/L) 29.67±2.34 29.80±1.10 27.33±1.37 
sO2 (%) 78.67±11.78 71.60±12.50 83.00±10.81 
Na (mmol/L) 137.17±2.32 136.20±2.17 140.00±1.41 
K (mmol/L) 4.80±.60 5.40±.48 4.15±.23 
iCa (mmol/L) 1.35±.04 1.24±.06 1.16±.04 
Glu (mg/dL) 287.67±132.66 249.40±81.17 238.00±38.69 
Hct (%Packed Cell 
Volume) 
37.00±1.41 37.60±1.14 37.83±1.94 
Hb (g/dL) 12.58±.50 12.78±.41 12.87±.68 
pCO2:partial pressure of CO2, pO2: partial pressure of oxygen, BE ecf: base excess of the extra cellular 
fluid (mmol/L), HCO3:bicarbonate, TCO2: total carbon dioxide content, sO2: oxygen saturation, Na: 
sodium, K: potassium, iCa: ionized calcium, Glu: glucose, Hct: hematocrit, Hb: hemoglobin  
 
